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The protozoan pathogen Toxoplasma gondii is a highly successful parasite that infects 
up to a third of the world’s population, causing morbidity and mortality in the 
immunocompromised and when acquired congenitally.  As an obligate intracellular pathogen, 
T. gondii has adapted to acquiring key nutrients from its host.  Unlike vertebrate cells which 
are capable of de novo adenosine synthesis, T. gondii must rely solely on the purine salvage 
pathway, necessitating the presence of host-generated adenosine.  CD73, present on vertebrate 
host cells but not T. gondii parasites, is a surface-anchored glycoprotein that catalyzes the 
conversion of AMP to adenosine, which is then sensed by the cell through transmembrane 
adenosine receptors. The enzyme is highly expressed in various tissues, including the brain, 
lymphoid organs, and in many immune cell subsets. 
To determine the role of CD73-generated adenosine in T. gondii infection, I infected 
wildtype and CD73-knockout mice with the Toxoplasma gondii ME49 strain via the oral 
route.  CD73
-/-
 mice did not succumb to reactivation of infection, and had fewer brain cysts 
developing in the CD73
-/-
 mice.  The reduced cyst burden was due to a defect in T. gondii 
differentiation to cyst-forming bradyzoites in the brain in the absence of CD73, and was 
independent of adenosine receptor signaling. In vitro differentiation in primary murine 
astrocytes and human fibroblasts was also CD73-dependent, and could be rescued by 
exogenous supplementation with adenosine or blocked with pharmacological inhibition of 
CD73, while treatment with an adenosine receptor agonist had no effect. Thus CD73-
  
generated adenosine directly promoted T. gondii persistence and differentiation to long-lived 
tissue cysts.  
To further investigate the reason for the reduced parasite burden in the CNS, I 
inoculated WT and CD73
-/-
 mice with T. gondii via peritoneal inoculation. Unexpectedly, 
CD73
-/-
 mice were markedly susceptible to T. gondii intraperitoneal infection. Susceptibility 
was associated with elevated IL1β, TNFα, IFNγ and nitric oxide production, and increased 
infiltration of neutrophils and T cells into the peritoneal cavity. CD73 expression on both 
hematopoietic and nonhematopoietic cells was required to prevent immunopathology, and the 
absence of CD73 promoted local dissemination of the parasite.  Thus, CD73 plays opposite 
functions in acute and chronic infections with a protozoan pathogen. 
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Significance 
Toxoplasma gondii is a significant human pathogen, infecting up to one third of the world 
population. It is also of significance in veterinary medicine, since it is a zoonotic infection.  
Current effective treatments for T. gondii infection are limited, and thus novel therapies and 
insights into T. gondii virulence offer potential benefits.  In addition, T. gondii biology offers 
insight into related organisms, especially apicomplexans and other intracellular protozoan 
parasites. 
Toxoplasma gondii 
General biology and life cycle 
 
Toxoplasma gondii is an obligate intracellular protozoan pathogen with a broad host 
range and tissue tropism. T. gondii traffics to the central nervous system following invasion and 
replication in the gut. In healthy individuals, the parasite forms tissue cysts which limit parasite 
replication but enable the parasite and host to avoid immune cell-mediated destruction and tissue 
inflammation.  Latent infection is common in healthy people, with prevalence estimated from 20 
to 80% depending on country.  Immunocompromised individuals can experience reactivation of 
infection, leading to toxoplasmic encephalitis.  Unusual among the apicomplexa, T. gondii can 
complete its asexual cycle within intermediate hosts (any warm-blooded animal) without needing 
to undergo sexual division in a vector or in the definitive host (felids). This allows the parasite to 
be transmitted between intermediate hosts, likely contributing to the great success and clonal 
expansion of this parasite (1).  T. gondii transmission is through ingestion of cysts or oocysts in 
contaminated meat or produce.  The cysts and oocysts rupture in the gastrointestinal tract (from 
enzymatic digestion and in response to low pH), liberating infective bradyzoites or sporozoites 
respectively. These zoites transform to tachyzoites, which rapidly invade epithelial cells lining 
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the small intestine (mainly the ileum).  Tachyzoites also invade immune cells in the lamina 
propria of the intestine, and dissemination of the parasite throughout the host is thought to be 
mediated by these infected immune cells(2, 3). Transport of live parasites to the central nervous 
system and skeletal muscle is mainly attributed to cells of the myeloid lineage, In the central 
nervous system, T. gondii invades neurons, astrocytes and microglia in which it establishes a 
chronic infection by differentiating to form long-lived tissue cysts (4, 5). 
 In North America and Europe the most common T. gondii strains are classified into three 
clonal lineages (types I, II, and III), although strains not belonging to these lineages are being 
increasingly isolated, particularly in wildlife in North America and in South America, Australia 
and Africa (6-10). Type I strains, such as RH and GT1, are highly virulent in rodents, and an 
infectious dose of one viable parasite can be lethal in one to two weeks (11). They are usually 
associated with a worse prognosis in humans. Type II strains (ME49, PTG) are of intermediate 
virulence, and can be sustained by rodent hosts long term.  Type III strains (CTG) are avirulent 
in rodents. 
Innate immunity to T. gondii 
Many components and cells of the innate immune system are critical for control of T. 
gondii, both in direct killing of parasites, as well as in induction of the adaptive immune response 
(12-15). Experimental depletion of T cells (16), B cells (17) and neutrophils (18) leads to 
increased susceptibility in mice.  Genetic knockouts of innate molecules and cytokines have 
elucidated the important roles of the adapter protein MyD88, the cytokines IL-12 (19) and IL-18, 
pattern recognition receptors (particularly toll-like receptors 2, 4, and 11) nitric oxide production 
via inducible nitric oxide synthase (iNOS), as well as other intracellular immune mediators such 
as IGTPases (20). Toll-like receptor recognition of T. gondii is mediated through TLR2, -4, and 
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the recently identified TLR11, which is active in rodents but nonfunctional in humans.  TLR11 
binds to profilin, a parasite protein implicated in gliding motility, invasion and host cell egress  
TLR11-deficient mice show increased susceptibility to T. gondii infection(12, 21).  Dendritic 
cells are the main cell type that recognizes T. gondii via TLR11 and initiates the immune 
response through the release of IL-12, although neutrophils and macrophages are also important 
sources of IL-12 (18, 22). NK cells are an early and important source of interferon gamma (23).  
The intracellular stages of the T. gondii lifecycle are required for parasite replication, and also 
help the parasite evade neutralization by the humoral immune system, but requires specific 
adaptations to survive. Thus while T. gondii induces a potent immune response, it also modulates 
key factors. 
The adaptive immune response to T. gondii 
 
T. gondii induces a robust Th1 response which protects against unchecked parasite growth 
both in the initial phase of infection as well as during latent infection. Although T. gondii 
tachyzoites disseminate to many distant organs, including lungs, liver, lymph nodes, spleen and 
heart, the parasite persists mainly in brain and skeletal muscle through formation of tissue cysts. 
Formation of cysts requires parasite differentiation to bradyzoites.  Bradyzoites are less 
immunogenic than tachyzoites, which likely promotes survival of both parasite and host.  The 
initial T. gondii CNS infection induces robust recruitment of immune cells, especially T cells and 
macrophages.  These cells are known to be necessary for the control of T. gondii proliferation, as 
demonstrated by various mouse models in which T cells or innate immune mediators are 
compromised (16). Control of parasite replication involves a variety of mechanisms, including 
killing of infected cells by cytotoxic T lymphocytes(24), starving the parasite of nutrients, and 
5 
 
release of inflammatory mediators (25).  The cytokine interferon gamma from CD4
+
 T cells and 
CD8
+
 T cells controls tachyzoite replication and promotes parasite killing by macrophages .  In 
addition to its importance during acute infection, IFN is also critical for control of T. gondii 
during latent infection, as ablation of this cytokine leads to fatal toxoplasmic encephalitis in 
chronically infected mice (26).  Nevertheless, IFN and various immune cell subsets have also 
been associated with immunopathology in susceptible hosts (27, 28), especially in response to 
highly virulent T. gondii strains (29) 
Similar to the periphery, the immune response to T. gondii in the CNS is dominated by 
IFNγ produced by CD4+ and CD8+ T cells. Depletion of IFNγ after the establishment of chronic 
infection leads to rapid recrudescence of T. gondii cysts, differentiation of bradyzoites to host 
cell-lytic tachyzoites, and is ultimately lethal. The cytotoxic T cell response is also important 
during chronic infection, as evidenced by infection of CD8
+
 T cell depleted or perforin deficient 
murine hosts (30, 31). 
Modulation of the immune response by T. gondii 
 
 As a highly successful pathogen, T. gondii modulates the immune response extensively.  
To disseminate from the initial site of infection, the parasite may induce the migration of infected 
dendritic cells and monocytes/macrophages (32).  The parasite also inhibits macrophage, 
neutrophil and dendritic cell cytokine release or activation (33, 34). Although the modulation of 
the immune response protects the parasite from the immune system, it also protects the host from 
pathological inflammation, and genetic susceptibility to lethal infection with less virulent strains 
of T. gondii may represent over-production of inflammatory cytokines rather than a failure to 
control parasite replication (27, 29, 35). The absence of regulatory factors such as IL-10 is lethal 
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for infected hosts, again underscoring the importance of a balanced immune response that 
inhibits parasite growth without inducing lethal immunopathology (36). 
T. gondii purine salvage 
 
T. gondii, like other apicomplexans, has evolved a strictly parasitic niche and 
consequently lost the ability to synthesize the purine ring de novo. Instead, the parasite salvages 
host adenosine through a parasite membrane transporter and two redundant intracellular salvage 
enzymes, adenosine kinase (AK) and hypoxanthine-xanthine-guanine-phosphoribosyltransferase 
(HXGPRT) (37) (Figure 1.1). Although neither enzyme is critical for parasite survival 
individually, double-knockout of both adenosine kinase and HXGPRT is lethal for T. gondii (37-
39), demonstrating the critical nature of the purine salvage pathway for parasite survival and 
replication. Interestingly, while T. gondii also possesses a highly active and abundant nucleotide 
triphosphate hydrolase (NTPDase), which can convert adenosine triphosphate sequentially to 
ADP and then AMP) (40), in addition to a dedicated adenosine transporter (41, 42), it lacks a 5’-
nucleotidase that can further convert AMP to adenosine, whereas host cells have both 
extracellular and intracellular 5’-nucleotidases in addition to the ability to synthesize purines de 
novo. Therefore the purine salvage pathway offers a promising target of drug development.  
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Figure 1.1. Current model of T. gondii purine salvage. Purines are salvaged from the 
cytoplasm of the host cell as adenosine (Ado) or inosine (Ino) via transporters on the parasite 
plasma membrane.  Within the parasite cytoplasm, Ado and Ino are phosphorylated to AMP and 
IMP by the enzymes adenosine kinase (AK) and hypoxanthine-xanthine-guanine-
phosphoribosyltransferase (HXGPRT), respectively.  The T. gondii nucleoside triphosphate 
diphosphohydrolase (NTPDase) is found in the parasitophorous vacuole (PV) and the PV 
membrane. Size of the arrows represents the contribution of each pathway to purine salvage in T. 
gondii. 
T. gondii stage differentiation 
 
T. gondii undergoes four distinct developmental stages, two of which develop strictly in 
the parasite’s definite hosts, felids.  All other warm-blooded animals can also harbor tachyzoites 
and bradyzoites, which replicate by asexual division known as endodyogeny.  After ingestion of 
tissue cysts or oocysts, bradyzoites are liberated in the small intestine, where they invade 
epithelial cells and differentiate into tachyzoites. Tachyzoites divide rapidly and disseminate 
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throughout the host. Parasitized immune cells are thought to transport the tachyzoites to the brain 
and skeletal muscle, a site of further T. gondii differentiation(5, 32).  In these tissues, a 
combination of host and parasite signals induce tachyzoite-to-bradyzoite conversion, leading to 
the formation of tissue cysts and the persistence of the parasite as a latent infection (43). 
This stage differentiation is critical for parasitism for two reasons.  First, tissue cysts can 
be ingested by susceptible hosts, allowing for successful transmission of the parasite to naïve 
hosts. Secondly, the cyst stage allows the parasite to remain dormant for the life of the host, 
sequestering bradyzoites from the immune response in the immunologically privileged central 
nervous system. Indeed, in adult humans, recrudescence of dormant infection following immune 
system inhibition (such as in AIDS or following cancer chemotherapy) remains the major disease 
risk.  Therefore understanding the mechanisms by which T. gondii persists in the CNS could 
enable timely therapeutic interventions for the immunocompromised.  
CD73 and Extracellular Adenosine 
CD73 (Ecto 5’-Nucleotidase) 
CD73, also known as ecto-5’-nucleotidase, is a 70 kDa cell surface glycoprotein that 
catalyzes the conversion of AMP to adenosine in the extracellular and pericellular space. CD73 
is highly conserved in primates, while mouse and human CD73 share 88% homology; chicken, 
zebrafish, and fruit flies also have CD73 homologs. CD73 is anchored to the plasma membrane 
as a homodimer through a glycophosphatidylinositol (GPI) linker covalently attached to its C-
terminus during posttranslational processing.  This attachment moiety may impart unique 
properties on proteins, including association with or enrichment of these proteins in lipid rafts.  
In the extracellular milieu, adenosine serves as a potent immune modulator through binding to 
adenosine receptors (Figure. 1.2).  CD73 itself has been shown to function as a T cell 
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costimulatory receptor (44, 45), and has also been proposed to act as an adhesion molecule on T 
cells, with an as yet unknown ligand on endothelial and epithelial cells promoting cell-cell 
attachment and T cell extravasation (46-49).  At the same time, CD73 expressed on endothelial 
cells has been shown to be involved in limiting T cell extravasation by downregulating adhesion 
molecules (50). In contrast, our lab has shown that epithelial cells in the choroid plexus mediate 
T cell infiltration of the CNS in experimental autoimmune encephalitis in a mechanism involving 
signaling through adenosine receptors (51). This interesting dichotomy may play a critical role in 
the immune response to T. gondii infection, especially during the acute phase of infection. 
 
 
Figure 1.2. CD73 and adenosine receptor signaling in inflammation.  Cell death or damage 
releases ATP into the extracellular milieu, which acts as a “danger signal” by binding to P2X and 
P2Y receptors and mediating immune cell recruitment, activation and function.  This cascade 
must be resolved by the concerted actions of CD39 and CD73, which break down ATP to ADP, 
AMP and finally adenosine. Adenosine is a ligand for P1 receptors, which largely mediate anti-
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inflammatory responses. Adenosine can also be taken up by adenosine transporters for 
intracellular salvage. 
Extracellular Adenosine 
ATP is released during tissue injury, infection and in inflammation and acts as a danger 
signal in the extracellular matrix, synergizing with other mediators (such as cytokines, TLR 
ligands, and specific antigens) to promote activation and migration of innate and adaptive 
immune cells through binding to P2X and P2Y receptors (52-55). At the resolution of 
inflammation, ATP’s potent effect is neutralized through extracellular enzymes that break down 
the nucleotide.  CD39 and CD73 sequentially convert extracellular ATP to ADP, AMP and then 
to adenosine. CD39 and CD73 have been implicated in immune system regulation (56). 
Adenosine itself modulates the inflammatory response by binding to a group of four G-coupled 
protein receptors known as P1 adenosine receptors.  A2A and A2B receptors are linked to Gs 
proteins which activate adenyl cyclase and thus elevate intracellular levels of cAMP, while A1 
and A3 are linked to Gi proteins and inhibit cAMP generation.  Downstream of A2A/A2B induced 
cAMP, the pleiotropic enzyme PKA interacts with various signaling cascades (ERK1/2, CREB) 
that lead to gene regulation or activation and cytoskeletal network rearrangement, to ultimately 
effect a shift in cell activation or responsiveness.  A1 and A3 signaling activates phospholipase C 
through the Gβγ subunits, which induces MAPK cascade and also feeds into growth and 
differentiation pathways.  The outcome of adenosine receptor signaling is based on cellular target 
and the microenvironment.  Interestingly, production of extracellular adenosine is often a 
multicellular process, with CD39 on neutrophils or regulatory T cells breaking down ATP to 
AMP, which may be further catabolized to adenosine by CD73-expressing platelets in the 
vicinity. The resulting molecule can target nearby platelets, neutrophils, T cells or endothelial 
11 
 
and epithelial cells. However, adenosine’s effects are highly localized, as it can be rapidly 
degraded to inosine by adenosine deaminase (ADA) or internalized by adenosine transporters. 
Extracellular adenosine in innate immunity and inflammation 
 In general, the outcome of adenosine receptor signaling in innate immune cells is 
anti-inflammatory.  However, a number of reports suggest that adenosine receptor signaling may 
also enhance or complement proinflammatory processes, such as in IL-6 and type I interferon 
production (57-60).  On the other hand, endogenous purine nucleoside signaling can also 
promote diseases such as cancer.  Tumor immune evasion through the release of T cell-inhibitory 
adenosine levels has been demonstrated using various murine and human models of cancer (61-
63). 
Purinergic Signaling and Neutrophils 
Indirectly, adenosine also antagonizes the expression of adhesion molecules on 
endothelial cells.  In addition to limiting accumulation via endothelial cells, adenosine has potent 
effects on neutrophils themselves, including inhibition of cytokine release and generation of the 
respiratory burst, inhibition of cellular adhesion to the ECM and to other cells, and ultimately 
induction of apoptosis (64-69).  On neutrophils, A2A adenosine receptor signaling inhibits 
extravasation and adhesion, limiting neutrophil accumulation at the site of inflammation (70-73).  
Since neutrophils are also involved in the generation of extracellular adenosine (74), they are 
well situated to regulating their own activities as well as that of neighboring cells. 
Purinergic Signaling in DCs and Macrophages. 
Dendritic cells and macrophages (including microglia, Langerhans cells, Kupfer cells and 
other tissue-resident myeloid-derived cells) express varying levels of all four adenosine receptors 
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and some subsets also express CD73 (75, 76). Thus these cells can respond to and potentially 
generate extracellular adenosine. Adenosine receptor signaling in dendritic cells generally 
inhibits production of pro-inflammatory cytokines and chemokines and tissue remodeling factors 
such as TNFα (77-79) and IL1β (80), MMP9 (81, 82).  As professional antigen presenting cells, 
DCs are well-situated to promote or thwart cell-mediated immune responses, and to skew said 
immune response towards a Th1 or Th2 pathway(83).  The response of DCs to adenosine receptor 
stimulation depends partially on their maturation state and subset (84, 85).  Schnurr et al. report a 
differentiation stage difference in the response of plasmacytoid DCs to adenosine. Immature DCs 
expressed mainly A1AR and were activated to release cytokines and migrate in response to 
adenosine, whereas mature DCs downregulated A1AR, upregulated A2AAR, and responded to 
adenosine by downregulating cytokine production(86).  Monocyte-derived DCs respond to 
adenosine receptor signaling by priming T cells towards a Th2 phenotype (87). 
Macrophages produce TNFα and IL-12 in response to LPS challenge, a process 
antagonized by A2A adenosine receptor stimulation (88-91). At the same time, LPS-induced IL-
10 production is enhanced (92, 93), so that the two pathways synergistically downregulate 
proinflammatory factors.  Likewise, microglia have been reported to produce IL-10 and 
downregulate LPS-induced TNFα in response to A2A, A2B and A3 signaling (94, 95). In 
general, macrophages shift from a classically activated to an alternatively activated phenotype in 
response to adenosine receptor ligation, which is consistent with the role of adenosine in 
promoting the resolution of inflammation and wound-healing.  
Extracellular adenosine and T cell mediated immunity 
Subsets of T cells express CD39 and CD73, and adenosine receptors. In the thymus, 
CD73 expression increases with T cell maturation. In lymphoid tissues, CD73 is highly 
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expressed on CD8
+
 T cells.  Among CD4
+
 T cells, the highest expression of CD73 is found on T 
regulatory cells (Tregs), which also express. CD73- or CD39-deficient Tregs are impaired in 
regulation of effector T cells (56). T cells express A2A. Signaling through A2A leads to 
suppression of T effector functions, such as cytokine release, proliferation and accumulation at 
sites of inflammation(96).  However, the effect of adenosine on T cell infiltration can be 
modulated by the local microenvironment. In experimental autoimmune encephalitis, the murine 
model for multiple sclerosis, CD73-generated adenosine enhances infiltration of pathogenic T 
cells into the CNS (51). 
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Synthesis 
The results presented in this study describe the dual role of CD73-generated adenosine in 
T. gondii pathogenesis. In Chapter 2, I show that CD73 promotes T. gondii chronic infection 
through a mechanism independent of adenosine receptor signaling. Analysis of the immune 
response to T. gondii in the CD73-deficient murine host showed a slight delay in T cell 
infiltration into the CNS.  Although initial parasite expansion and dissemination was unimpaired 
in CD73
-/-
 mice, cyst formation or persistence was reduced significantly, and the parasite burden 
during chronic infection was subsequently lower in CD73
-/-
 hosts.  Further experiments 
determined that CD73 expression on host cells harboring bradyzoites was required for efficient 
T. gondii cyst formation. Since the adenosine receptor agonist NECA did not rescue cyst 
formation in CD73
-/-
 astrocytes, and A1 and A2A receptor-knockout mice had a brain cyst 
burden similar to WT, I concluded that T. gondii purine salvage pathway involves the activity of 
CD73. 
 In Chapter 3, I describe the key regulatory role of extracellular adenosine in murine T. 
gondii infection. In contrast to the chronic infection model described in Chapter 2, here I 
describe experiments infecting CD73
-/-
 mice by the systemic intraperitoneal route. I found a 
profound defect in immune regulation during the acute phase of infection, with CD73
-/-
 mice 
exhibiting increased morbidity and mortality associated with an uncontrolled immune response 
to T. gondii.  I found increased recruitment of neutrophils and T cells, combined with elevated 
levels of IL1β, TNFα, IFNγ and nitric oxide, induced by infection in the absence of adenosine 
receptor signaling.  In Chapter 4, I summarize my results and present future directions aimed at 
addressing the many questions prompted by my findings. 
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CHAPTER 2 
 
CD73-GENERATED ADENOSINE FACILITATES TOXOPLASMA GONDII 
DIFFERENTIATION TO LONG-LIVED TISSUE CYSTS IN THE 
CENTRAL NERVOUS SYSTEM
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ABSTRACT 
Toxoplasma gondii is an obligate intracellular protozoan pathogen that traffics to the central 
nervous system (CNS) following invasion of its host. In the CNS, T. gondii undergoes 
transformation from a rapidly dividing tachyzoite to a long-lived, slow dividing bradyzoites-
contained within cysts. The role of extracellular adenosine in T. gondii pathogenesis has not been 
previously investigated. T. gondii utilizes host purines such as adenosine for its energy needs, as 
it is unable to make its own. Here, we show that CD73
-/-
 mice, which lack the ability to generate 
extracellular adenosine, are protected from T. gondii chronic infection, with significantly fewer 
cysts and reduced susceptibility to reactivation of infection in the CNS independent of host 
effector function. Parasite dissemination to the brain was unimpaired in CD73
-/-
 hosts, suggesting 
that the reduced cyst number is due to impaired parasite differentiation in the CNS. Confirming 
this, T. gondii tachyzoites formed fewer cysts following alkaline pH stress in astrocytes isolated 
from CD73
-/-
 mice compared to wildtype, and in fibroblasts treated with a CD73 inhibitor. Cyst 
formation was rescued in CD73
-/-
 astrocytes supplemented with adenosine, but not with 
adenosine receptor agonist 5'-N-ethylcarboxamidoadenosine. Further, mice lacking adenosine 
receptors had no defect in cyst formation. Based on these findings we conclude that CD73 
expression promotes T. gondii bradyzoite differentiation and cyst formation by a mechanism 
dependent on the generation of adenosine, but independent of adenosine receptor signaling. 
Overall, these findings suggest that modulators of extracellular adenosine may be used to 
develop therapies aimed at defending against human toxoplasmosis. 
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INTRODUCTION 
Toxoplasma gondii is an obligate intracellular protozoan pathogen that traffics to the central 
nervous system (CNS) following initial invasion and replication in the gut (1). Infection with T. 
gondii commonly occurs in humans by ingestion of contaminated meat. In healthy individuals, 
the parasite forms tissue cysts, which limits its replication but enables the parasite to avoid 
immune cell-mediated destruction. Reactivation of latent infection in immunocompromised 
individuals and vertical transmission during pregnancy can lead to severe disease (2, 3).  
Dissemination of the parasite throughout the host is thought to be mediated by infected immune 
cells, which transport live parasites to the CNS and skeletal muscle where T. gondii establishes a 
chronic infection by differentiating into long-lived tissue cysts (4, 5). 
Host cell-mediated immunity is the major deterrent against toxoplasmosis (6). The 
immune response in healthy individuals keeps T. gondii in check so that cyst-containing 
bradyzoites remain dormant in the CNS for the life of the host without overt clinical symptoms. 
This delicate balance between host and parasite survival is mediated both by host immune 
modulators and by T. gondii modification of host factors to promote its survival and transmission 
and to avoid excessive tissue damage leading to the host’s demise (6-8). 
Extracellular adenosine is a purine nucleoside generated by the sequential 
dephosphorylation of adenosine triphosphate (ATP) by the ectoenzymes CD39 and CD73 
(reviewed in (9)). CD73 is a GPI-anchored cell-surface glycoprotein that catalyzes the final and 
rate-limiting conversion of adenosine monophosphate (AMP) to adenosine (10). Adenosine 
mediates its effects by binding to four 7-transmembrane receptors: A1, A2A, A2B and A3. 
Adenosine receptors and CD73 are highly expressed on various cell types, including immune 
cells and CNS resident cells (11). Extracellular adenosine signaling functions to prevent 
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excessive inflammation by suppressing pro-inflammatory cytokines, inhibiting leukocyte entry 
into tissues through downregulation of adhesion molecules and chemokines, and triggering the 
production of anti-inflammatory cytokines such as IL-10 (12-14).  Further, CD73 expression and 
downstream adenosine signaling are critical for compensatory responses to tissue ischemia (13, 
15, 16). Therefore, extracellular adenosine produced as a result of CD73 acts on adenosine 
receptors to regulate inflammation and protect against collateral tissue damage. Recent studies 
from our lab showed that CD73 and adenosine receptor expression on choroid plexus epithelial 
cells mediates T cell infiltration in the CNS, while expression on brain endothelial cells regulates 
blood-brain barrier function (17, 18). 
The role of CD73 in T. gondii infection has not been previously explored. However, work 
by Blader et al. (19) showed that infection of human fibroblast with T. gondii two hours post 
infection resulted in the upregulation of genes associated with the immune response, including 
CD73. T. gondii, like other apicomplexa, need host purines, such as adenosine as they cannot 
synthesize their own (20). Two purine salvage pathways have been identified in T. gondii, 
involving the enzymes hypoxanthine-xanthine-guanine phosphoribosyltransferase (HXGPRT) 
and adenosine kinase (AK)(21).  T. gondii adenosine kinase (AK) activity is 10-fold higher than 
other purine salvage enzymes; and adenosine is the preferred source of purines for T. gondii (22). 
This suggests that host derived adenosine plays an important role in T. gondii pathogenesis. In 
this study, we set out to determine if CD73 is thus important for T. gondii pathogenesis.  
Interestingly, we found that CD73-knockout mice are less susceptible to chronic T. gondii 
infection, exhibiting reduced morbidity and mortality and markedly reduced cyst burden in the 
brain, compared to WT control mice. In an in vitro cell culture model that recapitulated the in 
vivo model, we found that addition of adenosine, but not activation of adenosine receptors 
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rescued cyst formation. Our findings suggest that CD73 contributes to T. gondii persistence in 
the CNS by promoting parasite differentiation. 
MATERIALS AND METHODS 
Mouse strains and in vivo infection 
Female C57BL/6 WT and CD73-knockout mice (11), provided by Dr. Linda Thompson 
(Oklahoma Medical Research Foundation, Oklahoma City), were bred in specific pathogen free 
conditions at Cornell University. Adenosine receptor A1 and A2A knockout mice were a gift 
from Dr. Jurgen Schnermann (NIH/NIDDK, Bethesda, MD) and Dr. Jiang-Fan Chen (Boston 
University School of Medicine, Boston, MA), respectively. All animal experiments were 
approved by Cornell University’s Institutional Animal Care and Use Committee For chronic T. 
gondii infection, mice were inoculated per-orally with 10 or 20 cysts of the ME49 strain and 
monitored for weight loss, survival and parasite burden. For determination of parasite cyst 
burden, T. gondii infected mice were euthanized and their brains were harvested and 
homogenized. Brain homogenates were centrifuged at 250 × g for 10 minutes, resuspended in 
PBS and aliquots were mixed with an equal volume of Lugol’s iodine for counting cysts using 
light microscopy. 
Parasite strains and maintenance 
Cysts of the type II T. gondii ME49 strain were maintained in outbred Swiss Webster 
mice (Taconic) (53). Tachyzoites of the type II ME49 and PTG strains were passaged in human 
foreskin fibroblasts (HFFs)(53) in DMEM media supplemented with 3% v/v fetal calf serum, 1 
mM penicillin/streptomycin, 1 mM L-glutamine, 25 mM HEPES buffer and 2-mercaptoethanol.  
Bradyzoites of the type II ME49 strain were isolated from cysts of infected Swiss Webster mice 
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through pepsin-HCl digestion (54), followed by passage in HFF fibroblasts 3-4 times before use 
in experiments. Parasites were purified from freshly lysed HFF monolayers by filtration with a 
syringe-top 3 µm pore filter and centrifugation at 500 × g for 10 minutes at 4C.  Parasite pellets 
were resuspended in complete DMEM with 3% FCS and counted using a haemocytometer. 
Histology 
 Brains from infected mice were fixed in 10% formalin and processed detection of T. 
gondii cysts at the Animal Health Diagnostic Center in the College of Veterinary Medicine’s 
Histology Core Facility of Cornell University. Polyclonal rabbit anti-T. gondii antibody was used 
to visualize cysts and the sections were counterstained with hematoxylin. 
Flow cytometry 
Immune cells isolated from the brain (as described above) were stained with 
fluorochrome-conjugated antibodies against CD3 (clone 17A2), CD11b (clone M1/70), and 
CD45 (clone 30-F11). Astrocytes isolated from the brain (as described above) and infected or 
uninfected with T. gondii were stained with fluorochrome-conjugated antibodies against SAG-1 
(mouse monoclonal anti-p30) and CD73 (rat TY/11.8). Human foreskin fibroblasts were stained 
with phycoerythrin-conjugated anti-human CD73 (mouse AD2).  Antibodies were purchased 
from eBioscience (CD3, CD11b, mouse CD73), BD Bioscience (CD45, human CD73), and 
Argene (SAG1).  Data was acquired on a FACS Canto II, and analyzed with FlowJo software. 
Quantitation of Gene Expression by qPCR 
Cultured astrocytes and tissues from mice were homogenized in TRIZOL Reagent 
(Invitrogen Life Technologies) and stored at -80C prior to total RNA extractions according to 
the manufacturer’s protocol. RNA was treated with DNase (Epicentre Biotechnologies) before 
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determination of nucleic acid concentration and cDNA synthesis with the High Capacity Reverse 
Transcription Kit (Applied Biosystems). Brain or astrocyte-derived cDNA was analyzed for host 
and parasite genes using real-time PCR SYBR Green Master Mix from KAPA Biosystems using 
appropriate primers (Table S1 (55)) and run on a BioRad CFX96 real time qPCR system. Gene 
expression was normalized to the housekeeping gene PGK1 and calculated using the 2
-Ct
 
method. Melt curve analyses were performed to ensure the specificity of qPCR product. 
Quantitation of T. gondii by qPCR 
Harvested brain and small intestine tissue samples from T. gondii infected mice were 
homogenized in PBS, pelleted and then digested (50-100 mg tissue samples) with Proteinase K 
(0.2 mg/ml) in lysis buffer (10 mM Tris pH 8.0, 100 mM NaCl, 25 mM EDTA, 0.5% SDS) 
overnight at 55°C. Genomic DNA was precipitated with isopropanol, washed with 75% ethanol, 
and resuspended in molecular grade water. Nucleic acid concentration was determined and 
quantitative PCR (qPCR) was performed using 100 ng of gDNA in KAPA real-time SYBR 
Green mastermix (Kapa Biosystems) and 200 nM primers for the multi-copy B1 gene of T. 
gondii (Table S1).A standard curve was generated using known numbers of tachyzoites, 
extracted as described above. 
Bradyzoite isolation 
Wildtype and CD73
-/-
 mice were orally infected with 10 ME49 cysts. Eight weeks after 
infection, brains were homogenized in PBS and cysts isolated as described in Materials and 
Methods. Bradyzoites were liberated using pepsin-HCl. 
T. gondii proliferation 
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To assess T. gondii proliferation (40), isolated astrocytes (as described above) and human 
foreskin fibroblasts (Hs27) were seeded into 96-well tissue culture plates and allowed to grow to 
confluence before inoculation with tachyzoites (PTG or ME49) or freshly isolated bradyzoites 
(ME49) at various multiplicities of infection (MOI) in complete DMEM with 3% FCS. Seventy 
two post-infection, 1 µCi of [5,6-
3
H] uracil was added to each well and plates were incubated for 
an additional 24 h. Plates were centrifuged at 500 × g, supernatants removed, and the cells were 
lysed with 0.5 M NaOH. Nucleic acids were precipitated with ice-cold 5% trichloroacetic acid 
before transfer to glass fiber filters with a Tomtec Mach II M cell harvester. Incorporation of 
radioactive uracil was determined utilizing a liquid scintillation beta counter (Perkin-Elmer Life 
Sciences). 
Astrocyte isolation and culture 
To generate astrocytes in vitro, one to three day old wild type and CD73
-/-
 mice were 
euthanized and the brains were removed aseptically. Brains were minced, triturated in PBS and 
homogenized with passage through an 18g blunt needle. Astrocytes were enriched through 
Percoll gradient centrifugation. Brain homogenates were resuspended in 30% Percoll and layered 
over 70% Percoll before centrifugation at 600 × g for 20 minutes at room temperature. The 30-
70% interface was collected and washed in PBS. Cells were resuspended in complete DMEM 
(with 1.5 g/L sodium bicarbonate, 10% fetal calf serum v/v, 1 mM penicillin and streptomycin, 1 
mM L-glutamine, 25 mM HEPES buffer and 2-mercaptoethanol) and transferred to tissue 
culture-treated flasks. After 24 hours of incubation at 37C to allow for astrocyte attachment, 
media was replaced with fresh complete DMEM and cells were allowed to grow to 80% 
confluence with periodic feeding with the same media. Microglial cells were detached and 
removed by 200 rpm shaking at 37C overnight and fresh media replacement. Astrocytes were 
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collected by trypsinisation and seeded onto sterile glass cover-slips for immunofluorescent 
staining experiments, 48-well plates for gene expression experiments, and 96-well plates for 
parasite proliferation assays. 
Dexamethasone Treatment 
Wildtype and CD73
-/-
 mice were infected with 10 cysts of T. gondii ME49. Thirty days 
post-infection, mice were given 5 mg/L dexamethasone 21-phosphate disodium salt (Sigma-
Aldrich, St. Louis, MO, USA) in drinking water. Water was replaced every second day, and mice 
were weighed and monitored for morbidity and mortality. 
T. gondii differentiation and immunofluorescence microscopy 
To assess T. gondii differentiation in vitro (45), astrocytes isolated from WT and CD73
-/-
 
neonates (as described in (56) and detailed in Text S1) were grown to confluence on sterile 
coverslips in 24-well tissue culture plates. The cells were then infected at a MOI of 1:2 with 
ME49 tachyzoites for 2 days at pH 7.2 in complete DMEM with 3% FCS at 37C and 5% CO2. 
The media was then replaced with complete DMEM-3% FCS at pH 8.0 to induce bradyzoite 
differentiation (replaced every 3 days to maintain alkaline conditions), and the cells were 
cultured at 37°C in air. In some cases the media was supplemented with adenosine (50 µM), 5′-
N-Ethylcarboxamidoadenosine (NECA, 10 µM), alpha,beta-methylene ADP (meADP, 50 µM) 
or vehicle (DMSO) during the T. gondii differentiation before fixing and staining the cells at 12 
days post-alkaline pH challenge.  For the differentiation time course, the cells were analyzed at 
2, 4, and 8 days post-pH increase. Cells were fixed in 2% paraformaldehyde for 20 minutes at 
room temperature, then blocked and permeabilized with 10% normal rabbit serum and 0.2% 
Triton-X 100 in PBS with 1% BSA. Intracellular staining was performed overnight at 4C with 
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rabbit anti-BAG1 (J.P. Dubey, USDA, Beltsville, Maryland) followed by goat anti-rabbit 
conjugated to Alexa Fluor 488 or Texas Red X (Invitrogen) and either Dolichos biflorus 
agglutinin (DBA) conjugated to rhodamine (Vector Labs, Burlingame, California) or mouse anti-
SAG1-FITC. Coverslips were washed and mounted with Vectashield Mounting Medium with 
DAPI (Vector Labs). Images were obtained on a Zeiss Axio Imager M1 fluorescent microscope 
utilizing AxioVision software.  For quantitation of cyst numbers, 25 adjacent fields per slide 
were scanned and the number of BAG1+DBA+ cysts enumerated. 
Data analysis 
Statistical analyses were performed with Graphpad Prism software. Two-tailed Student’s 
T-tests or 2-way ANOVA with Bonferroni post-tests were used to compare differences between 
groups.  Kaplan Meier survival curves were compared with the Mantel-Cox log rank test. 
Differences with a p-value below 0.05 were considered significant. 
RESULTS 
CD73
-/-
 mice are less susceptible to toxoplasmosis 
To determine the role of CD73 in T. gondii infection, C57BL/6 (WT) and CD73
-/-
 mice 
(11) were infected with 10 cysts of T. gondii ME49 strain (23) by oral gavage, and then 
monitored for survival, weight loss, and cyst burden. In WT mice, infection with this dose of 
parasites allows survival through acute infection (<14 days) and establishment of chronic 
infection. However, WT mice are susceptible to parasite reactivation in the CNS, and the animals 
ultimately succumb to toxoplasmic encephalitis.  CD73
-/-
 mice were significantly more resistant 
to chronic T. gondii infection than WT mice (Figure 2.1A-D). While both WT and CD73
-/-
 mice 
infected with a low dose of the ME49 strain of T. gondii survived the acute infection, WT but not 
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CD73
-/-
 mice died during chronic infection, with the onset of morbidity and mortality occurring 
8-10 weeks post-infection (Figure 2.1A). Weight loss monitored during infection confirmed that 
WT mice exhibited increased susceptibility to toxoplasmosis, losing significantly more weight 
during both acute and chronic infection (Figure 2.1B). In addition, the increased survival 
observed in CD73
-/-
 mice correlated with decreased parasite burden in the CNS during chronic 
infection (Figure 2.1C-D). Gene expression analysis showed that CD73 is expressed in the brain 
and that its expression increased over the course of infection in WT mice (Figure 2.1E). 
Therefore, these results suggest that CD73 promotes parasite persistence in the brain resulting in 
increased susceptibility to toxoplasmic encephalitis. 
Figure 2.1 CD73
-/-
 mice are resistant to chronic T. gondii infection. WT and CD73
-/-
 mice 
were infected with 10 cysts of the T. gondii ME49 strain and then monitored for (A) survival and 
(B) weight loss. (C) Cyst burden in infected mouse brains was quantified by light microscopy. 
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(D) Brain sections from T. gondii infected mice were stained by immunohistochemistry for T. 
gondii cysts and are shown with representative cyst distribution near the hippocampus from Day 
33 post infection (T. gondii cysts = brown, hematoxylin-stained nuclei = blue). (E) CD73 gene 
expression in WT mice during infection. Expression was normalized to the PGK1 housekeeping 
gene. Error bars represent the s.e.m. Significant differences based on two-tailed t-tests are 
displayed (* P<0.05, ** P<0.01, *** P<0.005). The data shown is representative of 3 
experiments using 3-5 mice per group per time point. 
CD73
-/-
 and WT mice show similar levels of T. gondii parasite burden in the brain during the acute 
but not chronic stages of infection. 
To assess whether the reduced parasite burden in CD73
-/-
 mice could be explained by failure of 
the parasite to establish infection in the intestinal ileum or to disseminate to the brain following oral 
infection, WT and CD73
-/-
 mice were infected with 20 ME49 cysts, then sacrificed at various time-
points post infection to determine parasite burden in the ileum of the small intestine, liver and brain by 
quantitative real-time PCR. Both strains of mice showed similar kinetics of parasite expansion and 
clearance during the acute stage of infection in the gut, as well as similar dissemination to the brain 
(Figure 2.2A and 2.2B). In the ileum of WT and CD73
-/-
 mice, T. gondii DNA was consistently 
detectable by day 3, peaked on day 7, then decreased significantly by day 14 (Figure 2.2A). Liver 
parasite burden similarly peaked at 7 days in both strains of mice before decreasing significantly by day 
14 (Figure 2.2B) Parasite dissemination to the brain was detectable by day 7 post-infection, and then 
increased markedly thereafter (Figure 2.2C). Despite the similar initial kinetics of T. gondii 
dissemination to the brain, PCR results confirmed that CD73
-/-
 mice had significantly reduced parasite 
burden in the brain during chronic disease compared to WT mice (Figure 2.2D). This reduced parasite 
burden in CD73
-/-
 mice was consistent with their reduced susceptibility to latent infection (Figure 2.1).  
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Figure 2.2  CD73
-/-
 mice have reduced parasite burden in the brain during chronic T. gondii 
infection. WT and CD73
-/-
 mice were infected with 20 cysts of the T. gondii ME49 strain and 
then sacrificed at various time-points during (A-C) acute and (D) chronic infection to determine 
parasite burden in the (A) small intestine ileum (A), liver (B) and brain (C and D) by real-time 
quantitative PCR.  Error bars represent the s.e.m. Significant differences based on two-tailed t-
tests are displayed (** P<0.01). The data shown represents one experiment with 3-5 mice per 
group per time point. 
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CD73
-/-
 and WT mice have a similar degree of leukocyte infiltration into the brain during 
T. gondii chronic infection. 
As previously reported (24), infection with T. gondii in WT mice is associated with 
infiltration of leukocytes into the brain by day 10 post-infection and remains elevated throughout 
the chronic stage of disease (Figure 2.3 top). The absolute number of leukocyte recruitment into 
the brains of WT and CD73
-/-
 mice was similar (Figure 2.3 top left), although a decrease in T 
cells (as a percentage of total CD45
+
 cells) was observed in CD73
-/-
 mice early in infection at day 
10 (Figure 2.3 top center), with a relative increase in CD11b
+
 cells (Figure 2.3 top right). Since 
overall leukocyte numbers and composition was similar in CD73
-/-
 compared to WT mice during 
chronic infection, the reduction in parasite burden observed in CD73
-/-
 mice at the same time 
points (Figure 2.1) was likely not due to increased leukocyte recruitment to the CNS. 
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Figure 2.3. Kinetics of the immune response to T. gondii infection in the brain. Wild type 
and CD73
-/-
 mice were infected with 10 cysts of the T. gondii ME49 strain and then sacrificed at 
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various time-points to determine brain leukocyte infiltration (top panels) and effector gene 
expression (bottom panels). Gene expression levels were normalized to the PGK1 housekeeping 
gene. Error bars represent the s.e.m. The data shown is representative of two experiments using 
2-5 mice per time point. 
Brains from T. gondii infected CD73
-/-
 and WT mice have similar immune effector gene 
expression kinetics. 
We next analyzed gene expression of effector molecules associated with T. gondii 
infection to determine if the resistance of CD73
-/-
 mice was mediated by an increased production 
of these molecules. Interferon gamma (IFNγ) is a cytokine critical for controlling T. gondii 
expansion and reactivation in the brain (25-29). In WT and CD73
-/-
 mice, we observed an equally 
substantial and sustained increase in IFNγ mRNA expression during the course of T. gondii 
infection (Figure2.3, bottom left). Another effector molecule important in the killing and 
inhibition of T. gondii growth is inducible nitric oxide synthase (iNOS) found in peripheral 
macrophages and the CNS (30). T. gondii infection led to increased expression of the iNOS gene, 
NOS2, in WT and CD73
-/-
 mice to a similar extent (Figure 2.3, bottom center). Likewise, no 
difference was observed during T. gondii infection in the upregulation of TNF-α mRNA, which 
is important in the control of toxoplasmosis in synergy with IFNγ (31) between WT and CD73-/- 
mice (Figure 23, bottom right).  These findings suggest that gene expression of effector 
molecules in the brain are not altered in the absence of CD73 and therefore are not responsible 
for protecting CD73
-/-
 mice from T. gondii chronic infection. 
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Expression of key adhesion molecules and chemokines in the CNS during T. gondii 
infection. 
Leukocyte infiltration into the CNS is mediated by chemokines and adhesion molecules 
secreted by brain endothelial cells, astrocytes and microglial cells in response to infection and 
autoimmune inflammation (32). Thus we evaluated expression of three key factors that have 
been identified in mediating immune cell entry into the CNS in response to infection and 
neuroinflammatory diseases. While MadCAM1 expression in the CNS was markedly 
upregulated by T. gondii infection, consistent with its role in promoting leukocyte adhesion to 
brain endothelium (33-35), no significant difference in the increases in MadCAM1 gene 
expression was observed between infected wild type and CD73
-/-
 mice (Figure 2.4 left).  
Vascular adhesion molecule 1 (VCAM1), which has been implicated in recruitment of immune 
cells during T. gondii infection (36, 37), also increased over the course of T. gondii infection in 
both wild type and CD73
-/-
 mice (Figure 2.4 middle). Interestingly, VCAM1 expression was 
reduced early (Day 10 and 15) during T. gondii infection in the brains of CD73
-/-
 mice (Figure 
2.4 middle), which correlates with the reduced T cell infiltrates observed in the brains of CD73
-/-
 
mice early in infection (Figure 2.3 top middle). Finally, the adhesion molecule/chemokine 
CX3CL1 (fractalkine), which is highly expressed in the CNS and recruits brain resident 
microglia and leukocytes into the CNS (32, 38, 39), was observed in the brains of naïve and 
infected mice, although CX3CL1 gene expression in wild type and CD73
-/-
 mice decreased at a 
similar level over the course of T. gondii infection (Figure 2.4 right). These findings suggest that 
the changes in gene expression of adhesion molecules in the brain are not dependent on CD73 
and therefore are not responsible for protecting CD73
-/-
 mice from T. gondii chronic infection. 
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Figure 2.4. Kinetics of MadCAM1, VCAM1 and CX3CL1 (fractalkine) expression in the 
brain following T. gondii infection. Wild type and CD73
-/-
 mice were infected with 10 cysts of 
the T. gondii ME49 strain and then sacrificed at various time-points to determine brain 
MadCAM1, VCAM1, and CX3CL1 gene expression levels. Gene expression levels were 
normalized to the PGK1 housekeeping gene. Error bars represent the s.e.m. The data shown is 
representative of two experiments using 2-5 mice per time point. 
Lack of CD73 enhances proinflammatory cytokine responses to T. gondii. 
To assess whether the decreased disease susceptibility of CD73
-/-
 mice to chronic T. 
gondii infection was associated with modified secretion of key proinflammatory cytokines which 
control toxoplasmosis, we cultured lymphocytes from the spleen, lymph nodes, and brain of wild 
type and CD73
-/-
 mice infected with T. gondii and restimulated the cells with soluble tachyzoite 
derived antigens (STAg). Lymphocytes isolated from the spleen, lymph nodes, and brains of 
CD73
-/-
 infected mice produced significantly higher levels of interleukin 12 (IL-12) upon 
restimulation compared to those from infected wild type mice (Figure 2.5 left). Consistent with 
increased IL-12 levels, IFN production was also increased in restimulated isolated lymphocytes 
from CD73
-/-
 mice compared to wild type (Figure 2.5 right). These data suggest that 
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lymphocytes from T. gondii infected CD73
-/- 
mice can produce more proinflammatory cytokines 
compared to those from wild type mice. 
 
Figure 2.5. Proinflammatory cytokine production from isolated and restimulated 
lymphocytes following chronic infection with T. gondii. Wild type and CD73
-/-
 mice were 
infected with 10 cysts of the T. gondii ME49 strain and then sacrificed during the chronic stage 
of infection (day 32). Spleen, lymph node (LN) and brain leukocytes were isolated and 
restimulated in vitro with 20 µg/ml of soluble tachyzoite antigens (STAg) or media alone 
(unstim) and the generation of IL-12 and IFNγ was measured by ELISA. Error bars represent the 
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s.e.m. Significant differences based on two-tailed t-tests are displayed (* P<0.05, ** P<0.01, *** 
P<0.005). The data shown represents one of two experiments using 2-7 mice per group. 
Infection and proliferation of T. gondii in astrocytes is not dependent on CD73 expression 
 To assess whether CD73
-/-
 cells in the CNS were less permissive for T. gondii infection 
or proliferation, we isolated WT and CD73
-/-
 astrocytes and assessed the ability of the parasite to 
infect and proliferate in these cells. Astrocytes from WT and CD73
-/-
 neonates were cultured and 
expanded in vitro and then infected with tachyzoites of the type II T. gondii strain PTG (Figure 
2.6A). Flow cytometric analysis of astrocytes from WT mice revealed two distinct populations of 
cells based on CD73 expression, with approximately 40% of the cells being CD73-positive 
(Figure 2.6A). Likewise, the proliferation of tachyzoites of the PTG and ME49 strains of T. 
gondii, as measured by 
3
H-uracil incorporation (40), was similar in both WT and CD73
-/-
 
infected astrocytes (Figure 2.6B and C).  These results indicate that T. gondii infection and 
replication of tachyzoites in astrocytes is not dependent on CD73 expression. 
46 
 
 
Figure 2.6. Proliferation of T. gondii in cultured astrocytes from wild type and CD73
-/-
 
mice. Astrocytes from wild type and CD73
-/-
 neonates were cultured and infected with T. gondii 
PTG strain tachyzoites. (A) Comparison of CD73 expression and T. gondii infection level 
(SAG1) in cultured astrocytes 72 h after infection. (B) and (C) Proliferation of tachyzoites of the 
PTG (B) and ME49 (C) strains of T. gondii in cultured astrocytes at varying multiplicities of 
infection (MOI) as measured using the uracil incorporation assay. Incorporation into uninfected 
astrocytes was subtracted from the counts per minute to generate ∆CPM. Error bars represent the 
s.e.m. The data shown represents one of three experiments. 
CD73 expression promotes bradyzoite/cyst persistence in the brain.  
Since T. gondii infected CD73
-/-
 mice have a reduced number of brain cysts compared to 
WTs (Figure 2.1), we next determined whether CD73 expression is required for T. gondii 
bradyzoite maturation.  We isolated brains of T. gondii infected WT and CD73
-/-
 mice during 
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acute (day 10 and day 15) and chronic (day 30) infection and determined mRNA expression of 
the SAG1 (tachyzoite specific) and BAG1 (bradyzoite specific) genes by qPCR (41-43). In both 
WT and CD73
-/-
 mice, tachyzoite SAG1 was highly expressed on day 10 but decreased on days 
15 and 30 (Figure 2.7A). Conversely, bradyzoite BAG1 was expressed at low levels on day 10 
and highly expressed on days 15 and 30 in both WT and CD73
-/-
 mice (Figure 2.7B). 
Interestingly, while BAG1 expression was highly expressed in both mouse strains at day 30 post 
infection, mice that lacked CD73 had significantly lower brain BAG1 expression levels 
compared to WT mice (Figure 2.7B). These results suggest that bradyzoites are generated in the 
brains of CD73
-/-
 mice similar to WT but do not persist or proliferate. To test the viability of 
encysted bradyzoites, we purified cysts from chronically infected WT and CD73
-/-
 mice and 
liberated bradyzoites using enzymatic digestion. These bradyzoites were used to infect 
fibroblasts, and their proliferation assessed using 
3
H uracil incorporation. We found that 
bradyzoites isolated from CD73
-/-
 hosts proliferate significantly less than those isolated from WT 
hosts (Figure A1). However, in vivo, the few cysts found in CD73
-/- 
hosts were capable of 
recrudescence if mice were treated with dexamethasone to induce immunosuppression (44) 
(Figure A2). Thus, while there is evidence that parasites isolated from CD73
-/-
 mice proliferate 
less well in vitro, this is not enough to significantly impact the outcome of dexamethasone-
induced toxoplasmic encephalitis. 
CD73 promotes tachyzoite to bradyzoite differentiation in astrocytes 
We next determined whether T. gondii differentiation from tachyzoites to bradyzoites 
might be impaired in resident CNS cells lacking CD73. Astrocytes from WT and CD73
-/-
 mice 
were isolated, cultured and then infected with ME49 tachyzoites (Figure 2.7C and Figure 2.8). 
After 8 days in culture, we could detect robust expression of constitutive (Tubulin 1), tachyzoite-
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specific (SAG1) and bradyzoite-specific genes (BAG1 and ENO1) in WT and CD73
-/-
 cell 
cultures (Figure 2.7C). Interestingly, expression of the constitutive gene Tubulin 1 was slightly 
decreased in CD73
-/-
 infected cells, while SAG1, BAG1 and ENO1 expression were significantly 
reduced in CD73
-/-
 cells compared to WT cells.  The reduction in bradyzoite genes (BAG1 and 
ENO1) in CD73
-/-
 host cells was significantly pronounced at this time-point. 
 
Figure 2.7. Gene expression profile of T. gondii tachyzoites and bradyzoites in the brains of 
infected WT and CD73
-/-
 mice and in cultured brain astrocytes. (A and B) WT and CD73
-/-
 
mice were infected with 10 cysts of the T. gondii ME49 strain and then sacrificed at various 
time-points during acute (day 10 and 15) and chronic (day 30) infection to determine the brain 
expression of the (A) tachyzoite SAG1 and (B) bradyzoite BAG1 genes. The data shown 
represents one of three experiments using 2-5 mice per time point. (C) Astrocytes were cultured 
from neonatal WT and CD73
-/-
 pups and then infected with ME49 tachyzoites to assess 
spontaneous differentiation of T. gondii in vitro by quantitative real-time PCR analysis of 
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constitutively expressed Tubulin 1, tachyzoite-specific SAG1 and bradyzoite-specific BAG1 and 
ENO1 genes. Parasite gene expression was normalized to host PGK1 housekeeping gene. Error 
bars represent the s.e.m. Significant differences based on two-tailed t-tests are displayed (* P< 
0.05, ** P<0.01, *** P<0.0001). 
 To determine whether the differentiation of T. gondii in CD73
-/-
 host cells was also 
impaired under bradyzoite-inducing conditions, we again cultured astrocytes from WT and 
CD73
-/-
 hosts and infected them with T. gondii ME49 tachyzoites.  At 2 days post infection, the 
pH of the culture media was increased from 7.2 to 8.0-8.1, to induce cyst formation (45). 
Confirming our quantitative gene expression data (Figure 2.7C) some tachyzoites (SAG1
+
) 
spontaneously differentiated to bradyzoites (BAG1
+
) even before alkaline pH challenge (Figure 
2.8A left panel).  Nevertheless, pH induction triggered substantial bradyzoite differentiation, 
with cyst formation observed after only 2 and 4 days in alkaline media (Figure 2.8A second and 
third panels), and mature cysts by 8 days post-induction (Figure 2.8A fourth panel and Figure 
2.8C).  Mature cysts, defined as positive for the bradyzoite marker BAG1 as well as the cyst wall 
component that binds Dolichos biflorus agglutinin (DBA) were quantified to compare the ability 
of astrocytes from WT and CD73
-/-
 mice to support cyst formation in vitro. Significantly more 
cysts were observed in astrocytes cultures from WT mice compared to those from CD73
-/-
 mice 
(Figure 2.8C). Consistent with this finding, analysis of BAG1 expression at the mRNA level by 
qPCR revealed significantly higher expression of this bradyzoite T. gondii gene in WT compared 
to CD73
-/-
 astrocyte cultures (Figure 2.8B). These results strongly suggest that CD73 expression 
is required for the efficient formation or maintenance of cysts in astrocytes. 
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Exogenous adenosine rescues T. gondii cyst formation in CD73-deficient host cells 
To investigate the mechanism by which CD73 promotes cyst formation or bradyzoite 
differentiation in vitro, we next determined whether exogenous adenosine, which mediates both 
adenosine receptor signaling as well as serving as a source of purines for parasites such as T. 
gondii can rescue the defect in bradyzoite maturation observed in mice and cells lacking CD73. 
We first determined by real-time PCR that three of the four adenosine receptors are expressed on 
astrocytes in addition to the ecto-enzymes CD39 and CD73 that generate adenosine from the 
breakdown of ATP (Figure 2.9A). As described above, astrocytes from WT and CD73
-/-
 mice 
were isolated, cultured and then infected with ME49 tachyzoites in increased pH medium (from 
7.2 to 8.0), to induce cyst formation in the presence of adenosine or vehicle control (DMSO). We 
observed that exogenous adenosine was able to significantly rescue T. gondii cyst formation in 
CD73
-/-
 astrocytes to levels similar to WT but not vehicle control  (Figure 2.9B). 
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Figure 2.8. Differentiation of T. gondii in cultured astrocytes from WT and CD73
-/-
 mice. 
Astrocytes from WT and CD73
-/-
 neonates were cultured and infected with T. gondii tachyzoites 
of the ME49 strain and analyzed for parasite differentiation (A) Immunofluorescence 
microscopy of infected astrocytes cultured at neutral pH (7.2; 1
st
 panel) or alkaline pH (8.0; 2
nd
, 
3
rd
 and 4
th
 panel) for 2 ,4, and 8 days (tachyzoites/SAG1 stained = red,  bradyzoites/BAG1 
stained = green, nuclei/DAPI stained = blue). (B) Quantification of T. gondii BAG1 gene 
expression in infected WT and CD73
-/-
 astrocytes normalized to host housekeeping gene PGK1. 
(C) Visualization and quantification of in vitro cyst formation in cultured WT and CD73
-/-
 
astrocytes after 8 d at pH 8.0 as determined by anti-BAG1 (green) and Dolichos biflorus 
agglutinin (DBA, red) staining; insets show cysts at higher magnification. Significant differences 
based on two-tailed t-tests are displayed (** P<0.01). 
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 We next asked whether adenosine receptor signaling was important in mediating 
bradyzoite cyst maturation by treating astrocytes with an adenosine analogue, 5'-N-
ethylcarboxamido adenosine (NECA).  NECA acts as a broad spectrum adenosine receptor 
agonist, but does not participate in the adenosine purine salvage pathway. Interestingly, we found 
that NECA had no effect on cyst formation (Figure 2.9B). To confirm that the differentiation 
defect in CD73
-/-
 cells was due to the absence of CD73 activity, we cultured astrocytes from WT 
and CD73
-/-
 mice with ME49 tachyzoites in the presence of the specific CD73 inhibitor 
alpha,beta-methylene ADP (meADP) which blocks the enzymatic activity of CD73. As 
anticipated, meADP had no effect on cyst formation in CD73
-/-
 astrocytes, whereas it 
significantly inhibited cyst formation in WT astrocytes (Figure 2.9B).  
Finally, to determine whether CD73 expression on other cell types also promoted T. 
gondii cyst formation, we infected the human fibroblast cell line Hs27 (which is commonly used 
to maintain T. gondii tachyzoites) with T. gondii ME49 under cyst-inducing conditions. Since the 
cell-line expresses CD73 (Figure 2.9C), we were able to show that inhibition of CD73 enzymatic 
activity with meADP led to a 2-fold reduction in cysts generated under high pH (Figure 2.9D), 
similar to what we observe with primary mouse astrocytes (Figure 2.9B).  Consistent with this 
finding, mice lacking the A1 or A2A adenosine receptors exhibited no defect in bradyzoite cyst 
formation, as their cyst burden was similar that of WT mice (Figure 2.9E). All together, these 
results confirm that CD73 promotes T. gondii bradyzoite differentiation through a mechanism 
involving adenosine acquisition rather than adenosine receptor signaling. 
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Figure 2.9. Exogenous adenosine rescues T. gondii cyst formation in CD73-deficient host 
cells independent of adenosine receptor signaling.  (A) Gene expression analysis of adenosine 
receptors (A1, A2A, A2B, A3), CD39 and CD73 on cultured astrocytes. Real-time quantitative 
PCR results are normalized to the house keeping gene PGK1.  (B) Astrocytes from WT and 
cd73
-/-
 neonates were cultured and infected with T. gondii tachyzoites of the ME49 strain in the 
presence or absence of adenosine (50 µM), the broad spectrum adenosine receptor agonist 
NECA (10 µM), or the CD73 inhibitor alpha,beta-methylene ADP (meADP, 50 µM). Cyst 
formation was assessed 12 days after continuous culture at pH 8.0 by immunofluorescence 
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microscopy to quantify Dolichos biflorus agglutinin (DBA) binding cysts.  (C) The human 
foreskin fibroblast line Hs27 was assessed for CD73 expression by flow cytometry (unshaded 
curve, CD73-PE labeled cells, shaded curve, unstained live cells).  (D) Cyst formation was 
quantified as described above following 8 days’ culture of T. gondii-infected Hs27 fibroblasts at 
pH 8.0 in the presence of DMSO or 50 µM meADP. Significant differences based on two-tailed 
t-tests are displayed (** P<0.01, *** P<0.001).  (E) Quantitation of brain parasite cyst burden in 
A1AR
-/-
, A2AAR
-/-
, CD73
-/-
 and WT mice infected with 20 cysts of T. gondii ME49 for 30 days (* 
P<0.05) 
DISCUSSION 
The ability of Toxoplasma gondii to infect a wide variety of warm-blooded hosts and virtually 
any nucleated cell poses a challenge in the control of this parasite. One reason that T. gondii is a 
successful parasite is its ability to differentiate to the slow-growing bradyzoite stage in skeletal 
muscle and the CNS, allowing the parasite to persist even in the face of a robust immune 
response (46, 47).  In this study, we established that the widely expressed host-derived enzyme, 
5’-ecto-nucleosidase (CD73), plays a significant role in T. gondii persistence during chronic 
infection. In mice infected with T. gondii, we observed a significant increase in CD73 expression 
in the brain, the major tissue parasitized during the chronic stage of infection.  Importantly, 
CD73
-/-
 mice were resistant to cerebral toxoplasmosis, with increased survival and reduced 
parasite loads in the brains of infected animals. This protection was observed despite similar 
kinetics of T. gondii dissemination into the brains of WT and CD73
-/-
 mice, suggesting that 
CD73 expression promotes T. gondii persistence or survival in situ.  
In the CNS, control of T. gondii infection is mediated by infiltrating leukocytes, 
particularly cytotoxic T lymphocytes that activate parasiticidal and parasitistatic mechanisms in 
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infected cells (6, 8, 26, 48). Recrudescence of infection occurs when there is a breakdown in 
immunosurveillance or in the absence of key mediators of parasite control, such as IL-12, IFN, 
iNOS, and TNF- (6). In CD73
-/-
 mice, protection from cerebral toxoplasmosis was not 
associated with elevated IFN or other effector molecules such as iNOS and TNF-
infected CNS. Moreover, the lack of CD73 on CNS resident cells did not alter T. gondii’s ability 
to proliferate. 
While T. gondii can synthesize pyrimidines de novo, it lacks the ability to synthesize 
purines, including adenosine (20). CD73 mediates the final rate-limiting step in the enzymatic 
chain that catalyzes the dephosphorylation of extracellular AMP to adenosine from ATP. High 
levels of adenosine in the extracellular space trigger its transport into cells by means of 
transporters (49). The transport of adenosine across cell membranes is the first step in the salvage 
of adenosine by T. gondii (50-52). Although deletion of the major adenosine salvage enzyme 
adenosine kinase (AK) alone is not lethal and only imparts a modest growth defect (21), whether 
deletion of AK impairs cyst formation has not been reported .  It is possible that under conditions 
where extracellular adenosine levels are diminished or absent such as in mice or cells lacking 
CD73, that there would be an overall deficit in the availability of adequate sources of adenosine. 
Such a deficit can have an impact on T. gondii’s ability to undergo efficient transformation to the 
bradyzoite or long-lived cyst stage. Thus, interference with adenosine uptake can be detrimental 
to T. gondii, as we observed in CD73
-/-
 mice, and in in vitro differentiation assays in glial and 
fibroblast cells expressing or lacking CD73. 
In summary, we demonstrated that CD73
-/-
 mice are protected from T. gondii induced 
mortality and morbidity. Ablation of CD73 renders T. gondii incapable of efficiently establishing 
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latent infection as CD73
-/-
 mice have dramatically decreased cyst burden than WT mice. We 
show that glial cells from CD73
-/-
 mice are unable to sustain cyst differentiation or survival. 
While addition of adenosine rescues the cyst maturation defect, our results show this is not medi-
ated by adenosine receptor signaling. Further, inactivation of CD73 enzymatic function with a 
pharmacological inhibitor significantly reduces cyst formation in WT astrocytes and human 
fibroblasts. Although the precise mechanism of how T. gondii may acquire host adenosine for its 
survival is not yet clear, these findings clearly indicate that inhibitors to CD73 or adenosine 
might be important targets for therapy in limiting the growth or survival of Toxoplasma gondii 
and other apicomplexan parasites. 
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CD73-GENERATED ADENOSINE IS CRITICAL FOR IMMUNE 
REGULATION DURING TOXOPLASMA GONDII INFECTION 
 
 
Deeqa A. Mahamed, Margaret S. Bynoe 
 
 
  
 65 
 
ABSTRACT 
As an obligate intracellular pathogen, the apicomplexan parasite Toxoplasma gondii  evades 
immune system-mediated clearance by undergoing stage differentiation to persist indefinitely in 
susceptible hosts. Previously, we found that mice deficient in the ecto-enzyme CD73, which 
generates adenosine in the extracellular matrix, were significantly resistant to acute and chronic 
toxoplasmosis after oral infection with the T. gondii type II ME49 strain.  Resistance in CD73-
knockout mice was due to a delay in parasite differentiation in the CNS.  To further clarify the 
role of CD73 and extracellular adenosine in T. gondii pathogenesis, we infected wildtype and 
CD73KO mice with ME49 cysts systemically by the intraperitoneal (IP) route. In contrast to oral 
infection, IP-infected CD73KO mice were highly susceptible to immune-mediated pathology, 
with significantly increased infiltration of neutrophils and T cells into the peritoneal cavity.  
Administration of the adenosine receptor agonist NECA to infected CD73
-/-
 mice protected them 
against immunopathology, suggesting absence of CD73-generated adenosine led to the increased 
susceptibility in these mice. Peritoneal exudate cells from infected CD73KO mice generated 
higher levels of the inflammatory mediators nitric oxide, TNF, and IL1, without enhanced 
parasite killing or clearance. Bone marrow chimeras established that CD73 expression on both 
hematopoietic and nonhematopoietic compartments contributes to limiting T. gondii-induced 
immunopathology. In addition, mice deficient in the adenosine receptor A2A were more 
susceptible to immunopathology during intraperitoneal infection with T. gondii, compared to 
wildtype mice. Thus extracellular adenosine is a key molecule that regulates the immune 
response to an intracellular pathogen and promotes host survival. 
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INTRODUCTION 
Toxoplasma gondii is an obligate intracellular protozoan pathogen with a broad host range and 
tissue trophism.  During infection, T. gondii tachyzoites invade host cells and replicate rapidly 
before inducing a potent immune response that controls parasite numbers through direct killing.  
The immune response is dominated by IL-12 priming and subsequent IFNγ release by both 
innate and adaptive immune cells. Although a robust immune response is critical for controlling 
parasite-induced pathology, the immune response itself can cause severe pathology, and this 
balance may underscore differences in genetic susceptibility to toxoplasmosis among different 
hosts. 
CD73, present on vertebrate host cells but not T. gondii parasites, is a surface-anchored 
glycoprotein that catalyses the conversion of AMP to adenosine, which is then sensed by the cell 
through transmembrane adenosine receptors. The enzyme is highly expressed on endothelial 
cells, epithelial cells and lymphocytes. Extracellular adenosine is associated with regulation of 
local inflammation. Indeed, mice deficient in CD73 exhibit several defects in immunoregulation 
following diverse inflammatory challenges. CD73
-/-
 mice are more prone to sepsis (1), DSS-
induced inflammatory bowel disease (2), lung injury (3), and tissue ischemia, hypoxia and 
inflammation (4-6).  On the other hand, deletion or inhibition of CD73 may have therapeutic 
potential in cancer(7-9), multiple sclerosis (10) and chronic Toxoplasma gondii infection (11). 
Thus defining the role of this pleiotropic enzyme in inflammation and immunity may offer 
promising therapeutic targets. 
In this study, we identify the critical role of CD73 in regulating the immune response to 
T. gondii infection in an acute systemic model of toxoplasmosis. 
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MATERIALS AND METHODS 
Mice 
C57Bl/6 mice were purchased from Jackson Laboratories. CD73
-/-
 mice were obtained 
from Dr. Linda Thompson (OMRF). A1 and A2A mice were obtained from Dr. Jurgen 
Schnermann (NIH/NIDDK, Bethesda, MD) and Dr. Jiang-Fan Chen (Boston University School 
of Medicine, Boston, MA), respectively.  Mice were bred and housed under specific pathogen-
free conditions in the animal facility at Cornell University. All procedures performed on mice 
were approved by the Cornell University animal review committee. 
Toxoplasma gondii infection 
Wildtype (C57Bl/6, WT), CD73
-/-
 A1AR
-/-
, and  A2AAR
-/-
 mice were infected with 10, 20, 
or 40 T. gondii ME49 cysts or 1000 RH tachyzoites by intraperitoneal (ip) injection in 0.2 mL 
PBS.  Survival rates and weight loss were monitored daily. In some experiments, groups of mice 
were euthanized at 3, 6, and 9 days post-infection and tissues (spleen, MLNs, liver, pancreas, 
lungs, and brains), peritoneal exudate cells, and/or blood collected for further processing. 
Histology 
Terminally anesthetized mice were perfused with ice-cold PBS and tissues collected for 
histology. Epidydymal fat pads were fixed in 10% formalin and processed for histology  
Treatment with adenosine receptor agonists and antagonists 
Mice infected as described above with 20 ME49 cysts were treated the adenosine 
analogue NECA. 5'-N-ethylcarboxamido adenosine (Tocris Biosciences, Minneapolis, USA) was 
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solubilized in DMSO and resuspended in PBS and  was injected into CD73
-/-
 IP daily (starting 3 
days before infection) at a 200 µM concentration. The same final concentration of DMSO was 
used as vehicle controls. 
Isolation of Peritoneal exudate cells 
Naïve and infected mice were euthanized by inhalation of isoflurane prior to cell 
collection.  Eight milliliters of ice-cold PBS was injected into the peritoneal cavity of each 
mouse, followed by 2 minutes palpitation to dislodge adherent peritoneal cells.  The cells were 
then collected by aspiration with a syringe.  Peritoneal cells were centrifuged at 400× g for 5 
minutes and resuspended in complete RPMI (Cellgro) containing 10% v/v fetal calf serum, 1 
mM Penicillin-Streptomycin, 25 mM HEPES, 1 mM L-glutamine and 50 µM beta-
mercaptoethanol.  
Isolation of spleen and mesenteric lymph node cells 
Mesenteric lymph nodes and spleens were excised from euthanized mice and processed 
aseptically to generate single cell suspensions. Spleens were further treated to remove red blood 
cells using ACK lysing buffer (150 mM NH4Cl, 10 mM KHCO3, 100 µM EDTA). Cells were 
resuspended in complete RPMI media. 
Ex vivo Flow cytometry 
Single cell suspensions were incubated with antibody cocktails in FACS buffer (0.5% 
BSA, 0.009% NaN3 in PBS) for 15 minutes at 4-8 °C.  Antibody binding to the Fc receptor was 
blocked with 5 µg/mL rat anti-mouse CD16/CD32 antibody (FcBlock, BD Biosciences) prior to 
cell staining.  Cells were washed, resuspended in FACS buffer and samples acquired on a FACS 
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Canto II instrument using FACSDiva software.  Analysis of flow cytometry data was performed 
with Flowjo software. 
Cytospins 
Peritoneal exudate cells were labeled with CD45-APC and 1A8-FITC, then adhered to 
slides using a Cystospin. Cells were fixed with 2% paraformaldehyde, then mounted with 
Vectashield mounting media with DAPI. Slides were imaged with a Zeiss Axio Imager M1 
fluorescent microscope. 
Cell culture 
Spleen, mesenteric lymph node and peritoneal exudate cells were resuspended to 5 ×10
6
 
per mL media and cultured at 37°C in a 5% CO2 humidified incubator for 24 or 48 hours with or 
without soluble tachyzoite antigen (STAg). Cell-free supernatants were collected and stored at -
20°C until analysis. 
Cytokine ELISAs 
Cell culture supernatants and serum of naïve infected mice were analyzed for IL1beta, 
TNFalpha, IL12 and interferon gamma using Ready-SET-GO ELISA kits from eBioscience 
according to the manufacturer’s instructions. 
Measurement of nitrite production 
Nitric oxide levels in serum and cell culture supernatants were quantified through 
measuring the presence of nitrite using the Griess Reagent(12). Briefly, an equal volume of cell 
culture supernatant was incubated with the Griess reagent (0.1% N-1-napthylethylenediamine 
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dihydrochloride pre-mixed with 1% sulfanilamide in 5% phosphoric acid) and read at 550 nm in 
a BioTek plate reader. A sodium nitrite standard curve was used to quantify nitrite levels. 
 
 
Bone Marrow Chimeras 
Wildtype and CD73-deficient mice were lethally irradiated to ablate bone marrow cells 
(450 rads twice 4 hours apart).  Mice were then reconstituted with bone marrow cells from 
congenic wildtype or CD73
-/-
 donor mice. Each mouse received 10
6
 BM cells iv, and was placed 
on acidified water containing Bactrim for 10 days to reduce the risk of opportunistic infection.  
After 8-10 weeks, mice were infected with 20 T. gondii ME49 cysts ip.and monitored for 
survival and weight loss. 
Adoptive transfer 
RAG1
-/-
 mice were reconstituted with 10
7
 total spleen leukocytes per mouse from 
wildtype or CD73
-/-
 hosts by retro-orbital injection. One week later, mice were infected with 20 
ME49 cysts of T. gondii ip. and monitored for morbidity and mortality 
RESULTS 
Intraperitoneal infection with Toxoplasma gondii is lethal in CD73
-/-
 hosts 
Mice infected with T. gondii via the intraperitoneal route develop systemic inflammation, 
characterized by recruitment and activation of leukocytes in the peritoneal cavity, increased Th1 
cytokines in serum and release of acute phase mediators such as nitric oxide by responding cells. 
In the absence of CD73, we found a significant and lethal dysregulation of the immune response 
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to T. gondii, with increased morbidity and mortality in CD73
-/-
 hosts (Figure 3.1) infected with 
both the avirulent type II (Figure 3.1A and B) ME49 strain, or the highly virulent type I strain 
(Figure 3.2). Indeed, gross pathology of the peritoneal cavity show extensive fatty tissue necrosis 
(Figure 3.1C).  Histological sections of epidydemal fat pads showed acute inflammation and 
infiltration of cells in the infected CD73
-/-
 mice only (Figure 3.1D), suggesting that T. gondii 
infection induced recruitment and/or uncontrolled activation of immune cells. 
 
Figure 3.1. CD73
-/-
 mice are more susceptible to acute toxoplasmosis compared to wild-type 
mice. CD73-knockout (CD73
-/-
) mice and wildtype littermates were infected with T. gondii 
ME49 cysts by intraperitoneal injection. (A) Survival curve. (B) Weight loss (C) Gross 
pathology (D) H&E sections of epidydymal fat pads of infected mice. N=4-5 mice per group. 
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Figure 3.2.  Intraperitoneal infection with Toxoplasma gondii RH is more lethal in CD73
-/-
 
hosts. A) Survival of mice infected with 1000 RH tachyzoites i.p. (B) Weight loss. *** P < 
0.001, N=10 mice per group. 
Treating CD73
-/-
 mice with the adenosine receptor agonist NECA ablates susceptibility 
Since CD73 has both enzymatic and signaling properties, we next determined which 
functional absence led to the susceptibility of CD73
-/-
 mice to T. gondii infection. We infected 
WT and CD73
-/-
 mice with T. gondii ME49 cysts i.p., and simultaneously treated a group of 
CD73
-/-
 mice with the adenosine receptor analog 5'-N-ethylcarboxamido adenosine (NECA) and 
then monitored mice for weight loss and morbidity.  As we observed previously, CD73
-/-
 mice 
lost more weight and exhibited increased fatty tissue necrosis compared to wildtype mice (Figure 
3.3). We found that NECA, which has a high affinity for adenosine receptors and mediates 
receptor signaling but does not participate in the purine salvage pathway, protected CD73
-/-
 mice 
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from T. gondii-induced immunopathology compared to CD73
-/-
 mice treated with DMSO only 
(Figure 3.3). This suggested that the susceptibility of CD73
-/-
 hosts to T. gondii infection via the 
intraperitoneal route was due mainly to an absence of extracellular adenosine. 
 
Figure 3.3. CD73-generated adenosine protects mice against inflammation via adenosine 
receptor signaling. CD73-deficient mice treated with the adenosine analog 5'-N-
ethylcarboxamido adenosine (NECA) were protected from T. gondii-induced immunopathology 
compared to CD73
-/-
 mice treated with DMSO only.  (A) Weight loss (B) Gross pathology. 
The A2A adenosine receptor knockout mouse recapitulates the susceptibility to ip infection 
observed in CD73-deficient hosts 
All four adenosine receptors have been implicated in modulating the immune response.  
In particular, the A1 and A2A receptors have been shown to regulate various aspects of 
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inflammation, from recruitment of leukocytes to effector functions of the innate and adaptive 
immune response.  To determine which adenosine receptor played a dominant role in protection 
against T. gondii-induced immunopathology, we infected A1AR and A2AAR knockout mice, and 
compared their susceptibility to WT and CD73
-/-
 mice.  We found that, while A1AR
-/-
 mice had a 
similar outcome of disease as wildtype mice, A2AAR-deficient mice mirrored CD73
-/-
 mice in 
susceptibility (Figure 3.4). From this we concluded that the susceptibility of CD73
-/-
 mice was 
due to the absence of A2A adenosine receptor signaling. 
 
Figure 3.4. The A2A adenosine receptor mediates the protective effects of extracellular 
adenosine. Wildtype, CD73KO, A1 adenosine receptor (A1ARKO) or A2A adenosine receptor 
(A2AARKO) knockout mice were infected with 20 ME49 cysts of T. gondii and monitored for 
weight loss. 
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Hematopoietic and nonhematopoietic cells contribute CD73-generated adenosine to limit 
inflammation 
Next, we wanted to elucidate which cell-type was responsible for the generation of 
extracellular adenosine needed to limit T. gondii induced immunopathology.  Cells of both 
hematopoietic and non-hematopoietic lineage express CD73. About a third of naïve CD45
+
 
resident peritoneal cells express CD73, as determined by flow cytometry (Figure 3.5). The major 
cell population expressing CD73 is B cells, a quarter of which were positive as determined by 
flow cytometry (Figure 3.5).  Both CD4
+
 and CD8
+
 T cells were mainly CD73
+
, although overall 
there were few T cells in the peritoneal resident cell compartment. 
Figure. 3.5.  Constitutive CD73 expression on resident peritoneal exudate cells. Naïve WT 
peritoneal cells were immunostained with antibodies to CD45, CD4, CD8, CD73 and CD19 and 
analyzed by flow cytometry. 
Lymphocyte subsets and cells of the myeloid lineage are major sources of CD73-
generated adenosine. Endothelial cells, epithelial cells and fibroblasts are all known to express 
CD73, and CD73-deficiency on endothelial cells has been shown to promote lymphocyte 
extravasation and accumulation at sites of inflammation. To determine the contributions of these 
two compartments to the critical release of CD73-derived extracellular adenosine, we generated 
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chimeric mice in which WT and CD73
-/-
 mice were depleted of bone marrow cells through lethal 
irradiation, then rescued with the adoptive transfer of bone marrow cells from either WT or 
CD73
-/-
 donors. The recipient mice all survived the irradiation and were reconstituted with 
hematopoietic cells of donor cells. After infecting these mice with T. gondii ME49, we 
monitored survival and weight loss. We found that all CD73
-/-
 mice died by day 10 after 
infection, whether reconstituted with CD73
+
 or CD73
-
 bone marrow cells.  This suggests that 
CD73-expression on the non-hematopoietic lineage is critical for preventing immunopathology 
induced by T. gondii systemic infection. Interestingly, WT mice reconstituted with CD73-
deficient cells were partially susceptible, losing more weight and exhibiting increased mortality 
compared to WT mice reconstituted with CD73
+
 bone marrow cells. The mice succumbed later 
than CD73
-/-
 mice, and 1 out of 5 mice survived the acute stage of disease.  This suggests that 
early during infection, adenosine generated by nonhematopoietic cells is indispensable for 
controlling disease, which immune cell generated adenosine could be critical somewhat later 
during the acute stage of disease. 
 
Figure 3.6. Hematopoietic and nonhematopoietic cells contribute CD73-generated adenosine to 
limit inflammation. Bone marrow chimeras were generated and infected with T. gondii ME49 
cysts ip, then monitored for weight loss (A) and survival (B). 
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However, infection of RAG1
-/-
 mice, which lack T and B lymphocytes, reconstituted with 
either wildtype or CD73
-/-
 splenocytes before infection with T. gondii established that CD73 
expression was not necessary on T or B cells (Figure 3.7) to mediate protection. 
 
Figure 3.7.  Absence of CD73 in the T or B cell compartment does not confer susceptibility 
to T. gondii.  RAG1-knockout mice were reconstituted with splenocytes from WT or CD73
-/-
 
mice and compared in their susceptibility to T. gondii infection. WT mice were reconstituted 
with the same number of WT splenocytes, and CD73
-/-
 mice with CD73
-/-
 splenocytes. 
Susceptibility is associated with increased and sustained infiltration of neutrophils and T 
lymphocytes 
To determine the cause of the morbidity and mortality observed in the absence of CD73, 
we characterized the immune response to T. gondii i.p. infection in WT and CD73
-/-
 hosts. T. 
gondii infection led to infiltration of CD45+ cells in the peritoneal cavity, with a steady increase 
in the absolute numbers of cells over the course of acute infection (Figure 3.8A). The 
composition of the peritoneal exudate cells changed dramatically during the course of infection. 
Resident PECs are mainly ~60% B cells, 20-30% macrophages, and 10-20% T cells. During the 
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course of infection, the proportion of B cells decreases, and neutrophils, T cells, and NK cells 
numbers increase dramatically both proportionally and in absolute numbers (Figure 3.8B, C) 
 
Figure 3.8. Cell composition comparison of peritoneal exudate cells (PECs) from infected 
wildtype and CD73KO mice. Cells were collected by peritoneal lavage from wildtype and 
CD73KO mice infected i.p. with 20 T. gondii ME49 cysts and stained for immune cell markers 
for flow cytometric analysis and cytospin. (A) Absolute PEC counts (B)Cytospins of cells 
stained for CD45 (pseudo-colored red) and 1A8 (neutrophils, pseudo-colored green) (C) Cell 
composition on day 8 as quantified by flow cytometry. N=3-4 per group per time-point. 
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Parasite control in CD73-deficient mice is limited. 
The next question we wanted to address was whether the heightened immune response in 
CD73-deficient mice promoted better parasite control.  We collected peritoneal exudate cells, 
splenic leukocytes, and mesenteric lymph node cells from mice at 2, 4, and 8 days post-infection 
and assessed parasite burden by flow cytometry.  In the peritoneal exudate cells, both CD11b
+
 
and CD11b- cells were found to be harboring T. gondii tachyzoites during the acute stage of 
infection in both wildtype and CD73
-/-
 mice (Figure 3.9). Interestingly, more cells from the 
mesenteric lymph nodes of CD73-deficient mice were infected with T. gondii, suggesting that 
the parasite was able to disseminate more systemically in these animals. Nevertheless, during 
chronic infection we found that surviving CD73
-/-
 mice recovered and had reduced parasite 
burden in the brains (Figure 3.12), which we find consistent with our previous findings that 
CD73 promotes T. gondii persistence in the CNS during chronic infection. 
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Figure 3.9. Parasite dissemination during acute infection. Mice were infected with 20 cysts of 
ME49 and euthanized 2, 4, or 8 days later. Peritoneal exudate cells mesenteric lymph node and 
spleen leukocytes were collected and stained for CD11b and T. gondii p30 to quantify parasitized 
cells by flow cytometry. N=3 per group per time point. 
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Increased inflammatory mediators in the absence of extracellular adenosine 
The greatly perturbed cellular infiltration and immunopathology observed in T. gondii 
infected CD73
-/-
 mice suggested the differences could be rooted dysregulated cytokine 
production. We thus analyzed the sera an cell culture supernatants of mice infected with T. 
gondii ip.  We found that CD73
-/-
 mice had elevated acute phase mediators such as IL1β, TNFα 
and increased nitric oxide (Figure 3.10 A-C). CD73
-/-
 mice also exhibited elevated IFNγ in serum 
(Figure 3.10 E). Surprisingly, IL-12 was dramatically reduced in the sera of CD73
-/-
 mice (Figure 
3.10 D). 
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Figure 3.10. Dysregulated cytokine responses in CD73
-/-
 mice.  Spleen, peritoneal exudate or 
mesenteric lymph node cells from WT and CD73KO mice infected with 20 ME49 cysts for 8 
days were cultured in vitro  with T. gondii antigens (STAg, 20 g/ml) for 48h then assayed for 
IL1-beta (A) or TNF-alpha (B) production by ELISA. (C) Peritoneal exudate cell nitric oxide 
production as measured with the Griess reagent. (C) Serum IL-12 (D) Serum interferon gamma. 
In further experiments, we found that IL-12 production was significantly depressed in 
CD73
-/-
 mice whether infected with live parasites or stimulated with T. gondii soluble antigens 
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(STAg) (Figure 3.10). Despite the reduced IL-12, STAg alone could recruit elevated neutrophils 
in the absence of CD73 (Figure 3.11). 
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Figure 3.11. Reduced IL-12 secretion by peritoneal exudate cells from CD73
-/-
 mice. Naïve 
wildtype and CD73
-/-
 mice were injected i.p. with 20 ug/ml STAg  or 1 ug/ml LPS in PBS 
followed by isolation of PECs and restimulation with STAg or LPS in vitro (n=3 per group). 
.
Neutrophils
WT CD73
-/-
0
5
10
15
P
e
rc
e
n
t 
o
f 
C
D
4
5
+
 c
e
ll
s
 
Figure 3.12. Increased neutrophil recruitment into the peritoneal exudate cell compartment 
in CD73
-/-
 mice after sTAg treatment. WT and CD73
-/-
 were injected with 25 ug of STAg ip. 
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PECs were collected 2 h later and analyzed by flow cytometry for neutrophil recruitment 
(1A8
+
CD45
+
). N= 3 mice per group. 
CD73
-/-
 mice retain a moderate resistance to chronic T. gondii infection despite early acute 
susceptibility 
 We next wondered if the enhanced susceptibility observed in response to acute 
intraperitoneal infection in CD73
-/-
 hosts was retained during chronic infection, despite our 
earlier finding of resistance in this strain to oral infection. We found that CD73
-/-
 mice did not 
show increased susceptibility to chronic infection if they survived the acute stage of disease 
(Figure3.12) as measured by cyst burden in the brain or morbidity. These results are in 
agreement with those we previously observed in peroral infection (11), and confirm the 
importance of CD73 for T. gondii persistence in the CNS. 
 
 
Figure 3.12. CD73
-/-
 mice do not have increased susceptibility to chronic infection. Mice 
infected with T. gondii ip were monitored for survival and weight loss. (A) Survival (B) Weight 
loss. (C) Cyst counts per brain in surviving mice. 
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DISCUSSION 
Infection with T. gondii via intraperitoneal injection induces rapid immune cell 
infiltration and a robust immune response in mice. The genetics of both the host and parasite 
influence the outcome of infection. The immune response is dominated by a pro-inflammatory, 
Th1 skewed response that is both critical for resistance and also detrimental to the host if not 
tightly regulated.  In the current study, we found that the ectoenzyme CD73 was critical for 
limiting immunopathology and survival of mice infected with T. gondii via the intraperitoneal 
route. The protective effects of CD73 were mediated by the generation of extracellular 
adenosine, which prevented a pro-inflammatory cascade. We found that the A2A adenosine 
receptor was the major receptor implicated in protecting mice against hyper-inflammatory 
cellular infiltration in CD73-deficient mice.  These cells also secreted higher levels of 
proinflammatory mediators such as IL1β, TNF-α and nitric oxide, all of which are known to 
mediate bystander immunopathology.  Thus the cytokine dysregulation we observed in the 
absence of CD73 may promote tissue pathology during the acute response. 
In the absence of CD73, mice may exhibit a pro-inflammatory phenotype as a 
consequence of either lack of adenosine directly, or indirectly through the buildup of ATP, which 
is known to act as a danger signal.  Our data indicates that the adenosine receptor A2A is largely 
responsible for the limiting effect of adenosine in systemic inflammation induced by T. gondii ip 
infection.  
In conclusion, in this study we identified a host genetic factor that may be implicated in 
controlling immune cell-mediated pathology associated with a protozoan infection. 
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CHAPTER 4 
 
SUMMARY AND CONCLUSIONS 
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There are quite a few potential points of interaction between CD73, extracellular 
adenosine and Toxoplasma gondii pathogenesis.  Firstly, when T. gondii cysts are ingested by the 
host, the liberated bradyzoites differentiate to tachyzoites and invade the epithelial cells lining 
the small intestine epithelium.  These cells express CD73, and can respond to adenosine receptor 
signaling (1, 2). Secondly, dissemination of T. gondii to other tissues requires trafficking through 
barriers such as the epithelium of the small intestine, the endothelium of blood vessels, and the 
blood brain barrier. Adenosine receptor signaling has been shown to modulate the integrity of all 
of these biological barriers.  In addition, the immune response to T. gondii is a critical 
component of the pathogenesis of this parasite, and adenosine regulates many aspects of both 
innate and adaptive immunity, such as cell migration, activation, cytokine production and 
resolution of the immune response.  Finally, unlike vertebrate cells which are capable of de novo 
adenosine synthesis, T. gondii must rely solely on the purine salvage pathway, necessitating the 
presence of host-generated adenosine within host cells. Limiting access to adenosine may thus 
affect T. gondii survival or virulence, as the nucleoside is an important intermediary for many 
metabolic and signaling pathways. 
To determine the role of CD73 in T. gondii infection, we infected wildtype and CD73-
knockout mice with the T. gondii ME49 strain via the oral route. We found that while CD73
-/-
 
mice were protected from acute T. gondii oral infection, the most significant impact of CD73 
was in the CNS, with strikingly attenuated chronic stage infection.  CD73
-/-
 mice did not 
succumb to reactivation of infection, and developed fewer brain cysts. 
One possibility for the attenuated chronic infection in CD73
-/-
 hosts could be due to 
differences in the early kinetics of parasite dissemination.  We found that T. gondii proliferation 
and dissemination between wildtype and CD73-deficient hosts was similar early during 
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infection.  The parasite initially expanded in the small intestinal ileum, then was detectable in the 
spleen, liver and lungs, all of which saw a peak in parasite burden 7-10 days post-infection, 
before parasite numbers were curtailed efficiently.  In contrast, T. gondii was detectable in the 
brain a little later than in the viscera, but continued to expand without a significant contraction in 
numbers.  Instead, analysis of parasite differentiation genes show a major shift to bradyzoites and 
histological evidence confirm parasite cysts by one month after infection. 
Interestingly, in comparison to wildtype C57BL/6 mice, the reduced cyst burden in 
CD73
-/-
 mice was directly attributable to a delay or defect in tachyzoite-to-bradyzoite 
differentiation, which we define by a reduction in tachyzoite-specific SAG1 expression and a 
concomitant increase in bradyzoite specific BAG1 gene expression in the brain.  Analysis of 
IFNγ, iNOS and TNFα gene expression by qRT-PCR revealed that CD73-/- and WT mice had 
similar levels of these immune response genes known to inhibit T. gondii proliferation in the 
brain. This suggested that CD73 could promote T. gondii bradyzoite differentiation directly.  To 
test this hypothesis, we isolated astrocytes from WT and CD73
-/-
 hosts and infected them with 
tachyzoites in vitro.  Astrocytes have been shown to harbor cysts in vivo, and have been shown 
to be permissive to T. gondii differentiation in vitro under cyst-inducing conditions.  We found 
that the CD73-dependent difference in T. gondii differentiation was maintained in astrocytes. In 
fact, after 8 days in culture, tachyzoites spontaneously expressed bradyzoite BAG1 mRNA in 
WT astrocytes.  Under high pH stress, bradyzoites fully differentiated to mature cysts, as defined 
by the detection of DBA+ BAG1+ cysts. Few cysts formed in CD73-/- astrocytes under the same 
conditions, which led us to conclude that CD73 promoted T. gondii cyst formation in astrocytes. 
Further in vitro and in vivo experiments revealed that adenosine, rather than adenosine receptor 
signaling on astrocytes, was responsible for the robust cyst formation observed in CD73+ 
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astrocytes. The phenomena could be confirmed in the human foreskin fibroblast cell line Hs27, 
which led us to conclude that CD73-generated adenosine directly promoted T. gondii cyst 
formation or persistence. 
Although the mechanism by which CD73 enhances T. gondii cyst formation is unclear, 
several possibilities present themselves. One intriguing possibility is that CD73 is incorporated 
into the parasitophorous vacuole membrane, which is derived from the host cell plasma 
membrane.  Since CD73 is a GPI-anchored protein, it may not be excluded from the nascent PV 
as T. gondii invades the host cell (3). Whether it is in fact incorporated into the PVM is difficult 
to ascertain, since antibodies to CD73 failed to recognize the protein after cell/tissue fixation. 
However, it is interesting that T. gondii expresses a highly active apyrase which, similar to 
CD39, generates AMP from ATP. This nucleoside triphosphate hydrolase (NTPDase) has been 
shown to be secreted into the vacuolar lumen and incorporated into the inner leaflet of the PVM, 
where CD73 would be localized if it is indeed retained during formation of the PV.  In addition, 
the PV is known to be in close proximity to mitochondria, and T. gondii infection has been 
shown to rapidly deplete the host ATP pool. Thus, one possibility is that adenosine is generated 
in the PV via the sequential dephosphorylation of host ATP to AMP by the parasite-encoded 
NTPDase , followed by AMP dephosphorylation by CD73, and culminating in the uptake of 
adenosine by the transporter on the parasite plasma membrane (Fig 4.1). The major drawback to 
this model is that it does not account for why the absence of CD73 does not impede tachyzoites 
replication, which would be predicted if CD73-generated adenosine is necessary for T. gondii 
purine salvage. It is possible that tachyzoites would have additional mechanisms to salvage 
purines, such as through manipulation of the host cell purine de novo pathway. 
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Figure 4.1. Proposed model of how CD73 may contribute to T. gondii purine salvage in an 
infected cell.  CD73 is incorporated in the inner leaflet of the PV membrane, where it is situated 
to generate adenosine from ATP in concert with T. gondii NTPDase. 
 
To further investigate the reason for the reduced parasite burden in the CNS, we 
inoculated WT and CD73
-/-
 mice with T. gondii via peritoneal injection. Unexpectedly, CD73
-/-
 
mice were markedly susceptible to T. gondii intraperitoneal infection.  The potential interactions 
and causes of these seemingly disparate results will be discussed later in this chapter. 
In contrast to our findings with oral infection, CD73-/- mice infected with T. gondii by 
the intraperitoneal route were highly susceptible during the acute stage.  Infection with a dose of 
T. gondii ME49 cysts that was not lethal for C57BL/6 mice led to a 50-100% mortality rate in 
CD73
-/-
 mice. The mice began to exhibit increased morbidity within 3 days of infection, 
suggesting either parasite- or innate immune response-mediated pathology. 
To define the mechanism by which CD73 protected mice against systemic T. gondii 
induced inflammation, we infected CD73-/- mice and treated them with the adenosine receptor 
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agonist NECA. NECA treatment protected CD73-/- mice, suggesting a role for adenosine 
receptor signaling.  To confirm, we infected A1 and A2A receptor knockout mice, and found that 
A2AAR
-/-
 mice were as susceptible as CD73
-/-
 mice.  Further in vivo experiments with bone 
marrow chimeras and RAG1
-/-
 mice established a role for both hematopoietic and 
nonhematopoietic lineage cells in generating adenosine via CD73, although T and B cells were 
not a critical source of CD73-generated adenosine. 
Although parasite dissemination to mesenteric lymph nodes was slightly elevated in 
CD73
-/-
 mice, the greatest differences we saw was in increased production of proinflammatory 
cytokines IL1β and TNFα, as well as IFNγ at later stages of infection. Our results also showed 
that nitric oxide production by PECs isolated from infected CD73
-/-
 mice was significantly 
elevated.  Nitric oxide is important for the control of parasite replication, but can also lead to 
tissue damage and pathology.  It would be informative to test whether pharmacological blockade 
of nitric oxide production protects CD73
-/-
 mice from T. gondii induced immunopathology.   
A deficit in CD73 enzymatic activity could lead not only to adenosine depletion, but also 
upstream ATP accumulation.  ATP is known to activate the NLRP3 inflammasome via P2X 
receptor signaling, leading to the release of active IL1β via caspase-1 processing of pro-IL1β (4). 
It is possible that in CD73-deficient mice, buildup of ATP could lead to inflammasome 
activation either via P2X7 signaling, or through lack of antagonism by adenosine, which could 
explain the observed increase in IL1β. However, the results with the A2A receptor knockout 
mice, which appear to recapitulate the susceptibility observed in CD73
-/-
, suggests a dominant 
role for adenosine receptor signaling, at least during the early stage of infection. It would be 
interesting to determine  the IL1β levels in A2A AR
-/-
 mice and compare them to CD73-knockout 
mice. Another approach would be to compare the susceptibility of CD39
-/-
 mice to T. gondii ip 
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infection, although those mice would also have reduced adenosine levels in addition to the 
expected accumulation of extracellular ATP. 
It is interesting that the route of infection with T. gondii has a striking effect on the 
outcome of infection in CD73
-/-
 mice. These mice are resistant to the acute phase of oral 
infection, yet are highly susceptible to intraperitoneal infection.  Similar effects may be seen 
when comparing different strains of mice, suggesting host genetic factors could impact the 
outcome of infection (5, 6). For example, Balb/c mice are resistant to both oral and 
intraperitoneal infection, while C57BL/6 mice are highly susceptible to oral infection but 
relatively resistant to intraperitoneal infection. And even within the same genetic background, 
the route of infection can give rise to different responses, as the local immune system may differ 
in cell composition, tendency to polarize the response towards a Th1, or Th2 or even a regulatory 
phenotype. Johnson reported a strain resistant to oral T. gondii infection while being susceptible 
to ip infection. It is likely that the regulation of the immune response in the peritoneal cavity 
requires the presence of adenosine to limit pathology, while other compartments (the GI tract or 
the CNS during chronic infection) may have multiple or redundant mechanisms to control 
immunopathology. Notably, the blood-brain barrier prevents neutrophils from accumulating in 
the CNS, whereas the peritoneal cavity does not have that additional barrier to leukocyte hyper-
infiltration. 
Aside from reducing pro-inflammatory cascades, extracellular adenosine is also 
implicated in promoting anti-inflammatory factors such as IL-10 and induction of suppressor T 
cells.  In particular A2B and A2A signaling induces IL-10 release from macrophages and microglia 
(7-9). Although we saw a modest decrease in IL-10 release from infected PECs from CD73
-/-
 
mice, the difference was not statistically significant. It is possible that other regulatory factors, 
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such as IL-4 and TGFβ, contribute to CD73-mediated protective effects of extracellular 
adenosine in T. gondii ip infection. 
In addition to iNOS-generated nitric oxide, interferon gamma induces other protective 
factors to limit T. gondii replication.  In infected mouse cells, treatment with IFNγ induces the 
accumulation of IRG proteins (IFN-inducible GTPases) around the parasitophorous vacuole, 
leading to membrane disruption and parasite-killing (10, 11).  In human cells, The enzyme 
indoleamine 2,3-dioxygenase (IDO)  degrades L-tryptophan, which has been shown to suppress 
T. gondii proliferation in various cells, including macrophages, astrocytes, epithelial cells and 
fibroblasts (12-14). IDO activity in the CNS is thought to be of greater importance than nitric 
oxide production by IFNγ-induced iNOS in human host cells. Thus it would be interesting to 
determine the role of adenosine receptor signaling in IDO-mediated control of T. gondii infection 
in human macrophages or fibroblasts.  Yet another pathway that may intersect with the 
extracellular adenosine-T. gondii interaction is the production of reactive oxygen species (ROS). 
ROS production can be induced by extracellular ATP in T. gondii infected macrophages (15), 
and since it is plausible that ATP or its metabolites, ADP andAMP are elevated in CD73
-/-
 mice, 
it would be informative to test the contribution of this pathway to the control of T. gondii cyst 
formation in CD73-deficient hosts. 
A major surprising result of the acute infection experiments was the notable reduction in 
IL-12 in CD73
-/-
 mice infected ip with T. gondii, despite significantly elevated IFNγ. Both 
induction of IFNγ and resistance to T. gondii infection is established to require IL-12 (16) 
although limited IFNγ may be produced in the absence of IL-12 (17).  One possible cytokine that 
may be involved is the Th1 cytokine IL-18, which has been shown to be negatively regulated by 
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adenosine (18), to induce robust production of IL1β and TNFα(19, 20), and to promote IFNγ 
production independent of IL-12(21). 
Based on the ubiquitous expression of CD73 in the brain and the important role of 
extracellular adenosine in modulating the immune response and maintaining functional barrier 
integrity in the GI tract, the blood brain barrier, and other important intersections of the immune 
response, the external environment and the first lines of defense against dangerous pathogens, 
CD73 and extracellular adenosine present potential targets for therapeutic interventions in many 
ways.  
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 Table 1. Murine and T. gondii primer sequences used in real-time PCR. 
Gene
 a
             Forward Primer             Reverse Primer 
PGK1 CTCCGCTTTCATGTAGAGGAAG GACATCTCCTAGTTTGGACAGTG 
CD73 CAAATCCCACACAACCACTG TGCTCACTTGGTCACAGGAC 
IFN CTTTAACAGCAGGCCAGACA GCGAGTTATTTGTCATTCGG 
iNOS ACATCGACCCGTCCACAGTAT CAGAGGGGTAGGCTTGTCTC 
TNFα GGTATGAGATAGCAAATCGGC CAGACCCTCACACTCAGATC 
MadCAM1 GGCAGCAGTATCCTCTCTGTAC GCATGGTGACCTGGCAGTGAAG 
VCAM1 TGCCGAGCTAAATTACACATTG CCTTGTGGAGGGATGTACAGA 
CX3CL1 GTGCTGACCCGAAGGAGAAA CACCCGCTTCTCAAACTTGC 
T. gondii Tubulin 1 CGCCACGGCCGCTACCTGACT TACGCGCCTTCCTCTGCACCC 
T. gondii SAG1 ATCGCCTGAGAAGCATCACTG CGAAAATGGAAACGTGACTGG 
T. gondii BAG1 GACGTGGAGTTCGACAGCAAA ATGGCTCCGTTGTCGACTTCT 
T. gondii B1 gene GGAGGACTGGCAACCTGGTGTCG TTGTTTCACCCGGACCGTTTAGCAG 
a
PGK1, phosphoglycerate kinase 1; IFN, interferon gamma; iNOS, inducible nitric oxide synthase; TNFα, tumor 
necrosis factor alpha; MadCAM1, mucosal vascular addressin and cell adhesion molecule 1; VCAM1, vascular cell 
adhesion molecule 1; CX3CL1, chemokine (C-X3-C motif) ligand 1 
 
  
102 
 
 
Figure. A1. . Proliferation of T. gondii bradyzoites isolated from wildtype and CD73
-/-
 
hosts. C57BL/6 and CD73
-/-
 mice were infected with 10 ME49 cysts and brain cysts isolated 8 
weeks later.  Bradyzoites were liberated and inoculated into human fibroblasts at various 
multiplicities of infection.  Incorporation of tritiated uracil was used to determine proliferation.  
Error bars represent the s.e.m. 
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Figure A2. Dexamethasone induced recrudescence of chronic T. gondii infection. Wildtype 
and CD73
-/-
 were orally infected with 10 ME49 cysts. Thirty days later, mice were treated with 
dexamethasone in the drinking water (arrow) and monitored for weight loss, mortality and 
morbidity.  (A) Weight loss (B) Survival. 
 
